






Title of Document: REGULATORY EFFECTS OF ACUTE AND 
CHRONIC ENDURANCE EXERCISE ON 
NITRIC OXIDE AND REACTIVE OXYGEN 
SPECIES IN HUMAN CIRCULATING 
ANGIOGENIC CELLS 
  
 Nathan T. Jenkins, Ph.D., 2011 
  





This dissertation research comprised three studies examining the effects of acute 
and chronic endurance exercise on circulating angiogenic cells (CACs). Because the 
balance between nitric oxide (NO) and reactive oxygen species (ROS) is a critical 
aspect of the physiological function/dysfunction of CACs, each study determined the 
effects of exercise on NO-ROS balance within a variety of CAC types.  Study #1 
demonstrated that regular endurance exercise is associated with greater basal 
intracellular NO levels in cultured CACs, and that one mechanism underlying this 
association was increased NADPH oxidase enzyme activity in the sedentary state. 
Study #2 suggested an association between a sedentary lifestyle and increased nitro-
oxidative stress in freshly-isolated CD34+ progenitor cells. Study #3 demonstrated 
that prior exercise attenuates high-fat meal induced-increases in mitochondrial-
derived intracellular ROS in CD31+ CACs. Overall, it is concluded that acute and 
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 Chapter 1: Introduction and Specific Aims 
Background 
Current estimates indicate that only 50% of cardiovascular (CV) disease cases can 
be explained by traditional CV risk factors including hypertension, hyperglycemia, 
hypercholesterolemia, and others (22), and only ~60% of the CV disease risk 
reduction through regular exercise can be explained by its effects on traditional risk 
factors (151). Recent evidence indicates that the number and function of circulating 
angiogenic cells (CACs) may account for some of the unexplained CV risk and 
reduction in risk through regular exercise. The term “CACs” refers to a variety of cell 
types that can maintain, repair, and regenerate the vascular endothelium (250). As the 
development of endothelial dysfunction is thought of to be the earliest event in the 
development of atherosclerosis (78, 179), the maintenance of a functional 
endothelium by CACs is a critically important physiological process in current CV 
disease prevention research. Epidemiological data have established associations of 
CACs with CV disease risk (reviewed extensively in Chapter 2), but the biological 
mechanisms underlying these associations are unclear. Further, growing evidence 
indicates that both acute and chronic endurance exercise increase the number of 
CACs. This increased CAC number has been proposed to enhance the capacity for 
endogenous vascular repair. However, the effects of exercise or training on functional 
aspects of CACs have not been adequately examined.  
Therefore, the overall aim of this dissertation research was to determine the 
effects of acute and chronic endurance exercise on molecular regulators of CAC 
function. The three studies contained herein examined angiogenesis- and oxidative 
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stress-related genes and intracellular free radicals in CACs to determine if acute and 
chronic exercise are associated with more favorable intracellular conditions for CAC-
mediated endothelial repair. Specifically, these studies focused on the regulation of 
nitric oxide (NO) and reactive oxygen species (ROS), as these molecules are 
important mechanistic regulators of a variety of CAC maintenance and repair 
functions, including mobilization, homing/migratory capacity, and secretion of 
angiogenic growth factors (61, 88, 250). In addition, ex vivo experimental inhibition 
of NADPH oxidase was performed in each experiment to determine the mechanistic 
role of this pro-oxidant enzyme relative to any effects of exercise or exercise training 
on CACs.  
Specific Aims 
Specific Aim 1. To determine the effects of acute and chronic endurance 
exercise on intracellular nitric oxide in putative endothelial progenitor cells. 
Study #1 (Jenkins et al., Am J Physiol-Heart Circ Physiol 2009; Chapter 3) 
determined the effects of acute and chronic endurance exercise on the intracellular 
environment of cultured endothelial progenitor cells (EPCs), which represent one 
type of CACs. It was hypothesized that acute and chronic endurance exercise would 
increase intracellular nitric oxide (NO) levels. Experiments with apocynin, an 
inhibitor of NADPH oxidase, were performed to examine whether alterations in NO 
could be explained by changes in NADPH oxidase enzyme activity.  
Specific Aim 2. To determine the effects of acute and chronic endurance 
exercise on intracellular NO, superoxide production and angiogenic gene 
expression in circulating CD34+ progenitor cells. 
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CD34+ progenitor cells in the circulation provide a pool of CACs and promote 
vascular repair (139, 209). In Study #2 (Jenkins et al., J Appl Physiol, in press, 2011; 
Chapter 4), intracellular superoxide ( O2     ·-
 
) and NO were assessed in freshly-isolated 
CD34+ cells of trained and sedentary men before and after acute exercise. The 
mechanistic role of NADPH oxidase underlying any effects of acute or chronic 
endurance exercise on NO or O2     ·-
 
 was determined by incubating cells with or 
without apocynin. It was hypothesized that acute and chronic endurance exercise 
would favorably influence the balance between NO and O2     ·-
 
 in freshly-isolated 
CD34+ PBMCs, and elevated NADPH oxidase activity in cells of the sedentary group 
would be a causal mechanism underlying these effects. It was also hypothesized that 
the expression of genes involved in the regulation of intracellular NO and O2     ·-
 
 levels 
would be consistent with greater antioxidant capacity and angiogenic function in the 
trained state. 
Specific Aim 3. To determine the effects of endurance exercise on CACs 
during postprandial lipemia.  
In study #3, the in vivo circulating environment was experimentally manipulated 
using a high-fat meal to induce postprandial lipemia (PPL) (Jenkins et al., 
Arterioscler Thromb Vasc Biol, submitted, 2011; Chapter 5). PPL is one of the most 
dramatic experimental perturbations of the CV and metabolic systems that can be 
performed in human subjects. PPL-induced hypertriglyceridemia has severe CV 
effects, including reduced NO bioavailability, increased systemic oxidative stress, and 
impaired endothelial function (237). However, acute exercise performed on either the 
preceding day (221) or during lipemia (160) can ameliorate PPL-induced endothelial 
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dysfunction. Importantly, PPL also causes pro-atherogenic phenotypes in circulating 
mononuclear cells, including upregulation of adhesion molecules and expression of 
proinflammatory genes (5, 153). CACs have never been examined during PPL, but 
exposure to an atherogenic environment promotes foam cell formation in cultured 
CD34+-derived EPCs (38), suggesting that these cells may be adversely affected by 
elevated lipids in vivo. As most people in Western societies are in a postprandial state 
most of the time, and atherosclerosis is a disease process mediated to a large extent by 
postprandial events (129, 192, 264), the results of this experiment are of high clinical 
relevance and public health significance. It was hypothesized that (i) PPL would 
reduce intracellular NO levels and increase the production of ROS by NADPH 
oxidase and/or mitochondria; and (ii) that these effects would be attenuated by a 




Chapter 2: Review of Literature 
Circulating Cells for Endogenous Vascular Repair 
The development of endothelial dysfunction is considered to be the first step in 
the etiology of cardiovascular (CV) disease and is a predictor for future CV events 
(189). Recent research has attempted to improve the understanding of physiological, 
cellular, and molecular processes involved in the maintenance of a functionally-
competent endothelial layer throughout the vasculature. Historically, it was thought 
that blood vessels lacked intrinsic mechanisms to repair cellular damage that causes 
endothelial dysfunction, especially damage resulting from inflammatory and 
oxidative injury that ultimately lead to atherosclerosis (179, 180). However, it is now 
known that although vascular endothelial cells have limited proliferative capacity, 
and are therefore unable to replace themselves to maintain a functional endothelial 
layer, there are several circulating cell types that perform critical functions for 
vascular endothelial maintenance, repair, and growth (12, 13). This dissertation 
research examined the effects of exercise on subpopulations of peripheral blood 
mononuclear cells (PBMCs), termed circulating angiogenic cells (CACs), with 
known roles in vasculogenesis and established relationships with endothelial function 
and CV disease risk. This chapter will review the current understanding of (i) the 
definition and functions of CACs, (ii) the relationship between CAC number and 
function and CV disease risk, (iii) cellular and molecular mechanisms linking CACs 
and CV disease, and (iv) the effects of lifestyle factors (i.e, physical activity an 
dietary habits) on CAC number and function. 
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Definitions and Functions of CAC Types 
Overview. Circulating angiogenic cells (CACs) are PBMCs that perform a variety 
of functions in maintaining the endothelial lining of blood vessels. CACs are thought 
to support blood vessel maintenance in at least one of the following ways: by 
migration to sites of endothelial damage and incorporate into the endothelial 
monolayer, thus providing a ‘fresh’ endothelial cell to replace a damaged one; 
contributing to angiogenesis by incorporating into new vessels as they sprout/expand 
into tissues requiring increased perfusion; and/or via the release angiogenic growth 
factors/cytokines, such as VEGF, in a paracrine manner at sites of new vessel growth 
or endothelial damage, aiding in recruitment and proliferation of endothelial cells or 
other CACs. For this literature review, the term “CAC” is used in a broad sense to 
refer to any cell type previously shown to perform one or more of these functions. 
Current data indicate that these cells comprise at least four CAC subpopulations: (i) 
endothelial progenitor cells (EPCs); (ii) circulating bone marrow-derived CD34+ 
progenitor cells (regardless of coexpression of an endothelial antigen; (iii) pro-
angiogenic hematopoietic cells; and (iv) circulating endothelial cells that originate 
from the vessel wall.  
Endothelial Progenitor Cells. Endothelial progenitor cells (EPCs) originate early 
in embryonic development where they are derived from a common mesenchymal 
stem cell that gives rise to the hematopoietic and endothelial lineages (termed the 
“hemangioblast”) (95, 96, 175). Until recently, it was thought that EPCs existed only 
in the prenatal environment in mammals, and angiogenesis during adulthood was 
believed to result from the sprouting of existing vascular endothelial cells to form 
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new blood vessels (175, 176). However, in 1997 Asahara et al. (13) discovered EPCs 
also exist as a rare subpopulation of PBMCs in humans that co-express a 
hematopoietic stem cell marker (CD34) and an endothelial marker. These cells had 
the capacity to re-endothelialize denuded vessels and contributed to de novo 
vasculogenesis in vivo (13). Thus, the authors identified an entirely new mechanism 
for the maintenance of vascular integrity in adults, and the clinical implications of this 
discovery of circulating cells with vasculogenic capacity have become increasingly 
recognized in recent years.  
EPCs contribute to repair of the endothelium by direct (i.e., engraftment) and 
indirect (i.e., paracrine secretion of angiogenic factors) mechanisms (26, 167). The 
exact degree to which EPCs perform endothelial repair by engraftment in damaged 
vessels is a controversial issue and has been found to be variable across several 
studies from animal models. One study found that 30% of endothelial cells were 
derived from progenitor cells in an allogeneic transplant model (97). Effect sizes in 
other studies have been smaller, ranging from ~10% (34, 210) to less than 5% (63); 
furthermore, several studies have found no evidence for EPC engraftment into the 
endothelium under physiological conditions (75, 76, 168, 238). This variability in 
results among published studies is probably related to the different experimental 
approaches among laboratories. The studies using severe ischemia models have most 
consistently supported a role for EPCs in formation of new blood vessels. In this 
experimental approach, a major vessel (usually the femoral artery) is ligated and the 
downstream tissues are subjected to a period of ischemia. The ischemic tissue 
becomes necrotic and the animal may lose the affected hindlimb. However, studies in 
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which ischemic tissues have been treated with EPCs have prevented the ischemia-
induced necrosis by promoting vascularization and restoring tissue perfusion (4, 11, 
186, 253). Data from these studies have been largely interpreted by the field as 
evidence for a role of EPCs in growth of new vessels (225). However, the hindlimb 
ischemia method is a severe experiment and its relevance to the physiological/clinical 
situation is unclear; i.e., there are no diseases (even peripheral arterial disease with 
severe ischemia) in which human patients experience an ischemic stimulus as 
dramatic and sudden as is seen in the mouse hindlimb ischemia model. A proposed 
alternative mechanism for EPC-mediated vascular maintenance is secretion of growth 
factors in a paracrine manner, and there is growing experimental evidence supporting 
this notion (85, 116, 263). Thus, the current thinking is that the major contribution of 
EPCs to the maintenance of vascular integrity is through pro-angiogenic functions, 
and that engraftment probably plays a minor role (85, 217) except in cases of severe 
tissue ischemia.  
Issues with EPC terminology based on cell origin and phenotype. It has recently 
become clear that a number of cell types are involved in the maintenance of 
endothelial integrity, and the term “EPC” is now considered a broad term and may 
apply to a number of specific cell subpopulations. Broadly speaking, two functionally 
distinct subpopulations of EPCs have been identified. Early EPCs organize into 
colonies in culture after ~1 wk, promote vascular repair by secretion of pro-
angiogenic growth factors at sites of endothelial injury, but have a low capacity to 
self-replicate and do not contribute to the formation of new vessels in vitro or in vivo 
(27, 92, 105, 260, 261). Conversely, late EPCs form colonies after an extended time 
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in culture (~2-4 wk), have robust proliferative capacity and contribute directly to 
neovascularization (72, 105, 144, 217, 261). It is extremely controversial whether 
EPCs of any particular subset or origin constitute “true” EPCs. Briefly, the confusion 
arises partly from the fact that there are additional circulating mononuclear 
subpopulations with angiogenic potential displaying substantial overlap with EPCs in 
their origin and phenotype. For example, some subpopulations of T-cells and 
monocytic macrophages co-express endothelial antigens and perform angiogenic 
functions (discussed below – see Angiogenic Monocytes and T-Cells). For these 
reasons, it has been suggested that the term “EPC” should be avoided unless the terms 
“endothelial” and “progenitor” can be defined using sophisticated methodologies to 
determine expression of specific cell surface markers and in vivo vasculogenic 
potential (92).  
Circulating CD34+ progenitor cells as CACs. Despite the widespread 
disagreement and controversies over cell definitions in the CAC field, cells 
expressing the hematopoietic stem cell antigen CD34 have been shown to contain 
progenitor cell subsets with angiogenic function. The presence of one or more 
endothelial markers, e.g. the vascular endothelial growth factor (VEGF) receptor-2 
(VEGFR2) [as originally reported by Asahara (13)], CD144, CD146, CD31, von 
Willebrand factor, and others have been used to identify EPCs from within the CD34+ 
cell pool (92, 105, 217). However, CD34+ cells are scarce in the adult human 
population [< 1% of total PBMCs, (184, 185)]. Thus, for practical purposes, the 
CD34+ population, without further subdivision into subsets expressing endothelial 
antigens, is often used for CAC studies (15, 42, 184, 254). Human and animal cell 
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therapy studies using autologous transplantation of CD34+ cells have found beneficial 
CV-related outcomes (89, 90, 98, 262), providing proof of concept for the angiogenic 
potential of circulating CD34+ cells. Recent reports indicate that CD34+ cell numbers 
are lower in patients with CV and metabolic diseases compared to healthy 
populations (55, 56), further supporting a link between CD34+ cells and systemic CV 
pathophysiology. However, it is unlikely that inclusion of only the CD34 antigen is 
sufficient for enumeration or functional analysis of CACs. This is because of the 
heterogeneity of CD34+ subpopulations as discussed above, and also because of the 
existence of a number of non-progenitor hematopoietic cells that can function as 
CACs, which will be described in the next section.  
Angiogenic monocytes and T-cells. Although most of the research on CACs has 
focused on the angiogenic actions of progenitors, there are also developmentally 
mature (i.e., CD34-) hematopoietic cells that co-express endothelial antigens and 
perform angiogenic functions. There is a large body of work on monocytes involved 
in angiogenesis, as monocytes have long been known to adhere to the endothelial 
layer of vessels undergoing collateral growth (182). Pharmacologic inhibition of 
monocyte recruitment from the bone marrow substantially reduced angiogenesis, 
suggesting that monocyte recruitment is indeed required for growth of new vessels 
(86). Although the mechanism by which monocytes support angiogenesis is not 
completely clear, there is evidence that monocytes become activated by signals, e.g. 
monocyte chemoattractant protein-1, secreted from the cells at the edge of vessels 
undergoing angiogenesis (106). These activated monocytes in turn secrete angiogenic 
growth factors such as VEGF to aid in further angiogenesis (9). This process requires 
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leukocyte-endothelial cell interactions that are mediated by the glycoprotein CD44 
(234) and monocyte invasion into the endothelium, which is coordinated by 
expression of adhesion molecules known as integrins (84). In addition, recent 
evidence indicates that monocytes are an exogenous source of nitric oxide (NO) for 
the vascular endothelium during angiogenesis (219). Particularly interesting was the 
finding that the NO synthase (NOS) isoform required for angiogenesis was the 
inducible NOS (iNOS) isoform, not the endothelial (eNOS) isoform (219), which is 
the major source of NO involved in endothelial cell-dependent vasodilation (102). 
These data came from experiments with iNOS and eNOS knockout mice, and only 
iNOS knockout mice had impaired angiogenic activities. However, the relative 
contributions of iNOS and eNOS to human CAC function in the context of vascular 
maintenance or disease-related impairments have not been investigated. 
The term “monocyte” is a general term referring to a number of different PBMC 
subpopulations involved in immune function, tissue inflammation, and host defense. 
The question of which monocyte cell fractions are responsible for angiogenic 
functions has received remarkably little attention in recent years, as the field has 
mostly focused on CACs that can be defined specifically as “EPCs” and not on other 
cells previously known to aid in angiogenesis. The monocytic CD14+/CD34- cell 
fraction has been reported to take on an endothelial cell phenotype in angiogenic 
culture conditions (79, 188). Indeed two separate publications have concluded that 
CD14+/CD34- (79) or CD14+/CD34low (178) cells are the primary source of human 
CACs. These cells have been shown to cooperate with CD34+ cells in angiogenesis 
(8, 79), suggesting that interactions among CAC types are important to consider. 
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Furthermore, some EPCs (i.e. early EPCs) display phenotypic overlap with 
monocytes/macrophages under certain conditions (e.g., phagocytosis of invading 
bacteria) (173, 261). Monocytic progenitors from bone marrow have been shown to 
adhere to injured endothelium and accelerate re-endothelialization by adopting an 
EPC phenotype (64). A population of monocytes has been reported to patrol healthy 
endothelium, recognize inflammation, and remove inflamed tissue by initiation of the 
early immune response (14). Together, these data suggest the existence of one or 
more populations of circulating angiogenic monocytes that display a high degree of 
functional plasticity and are probably an under-appreciated source of endothelial 
vascular repair.  
Similar to the case for monocytes, evidence has existed for many years that T-
cells are involved in angiogenesis. Over 20 years ago, T-cells were reported to 
produce a “lymphocyte angiogenesis factor”, and the degree of this angiogenesis 
factor secretion was found to decline with age (73). Recent evidence also indicates 
that angiogenic T-cells can home to sites of endothelial injury and secrete angiogenic 
growth factors in a manner similar to other CACs (43, 100, 120). Kushner et al. found 
that CD31+ T-cells secrete angiogenic growth factors in large quantities (120) and 
that their capacity to do so declines with age (122). In addition, data from studies on 
EPCs, specifically early EPCs, have implicated a role for T-cell subpopulations as 
CACs. Microarray gene expression analysis indicated that the commonly-used early 
EPC colony-formation assay (91) consists of hematopoietic cells with a gene 
expression signature similar to that of T-cells, but having little genomic resemblance 
to endothelial cells (41). Furthermore, depletion of T-cells before plating prevented 
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formation of CAC colonies from monocytic cells (227). Therefore, the role of 
angiogenic T-cells as CACs for endothelial repair has also been inadequately 
investigated. 
Circulating endothelial-like cells. The vessel wall itself has been implicated as a 
source of CACs (104, 259). Endothelial cells lining the vessel wall are generally 
considered to be fully differentiated cells with limited proliferative potential (20). 
However, using single cell assays for proliferative and clonogenic capacity, Ingram et 
al. showed that human aortic endothelial cells contain a complete hierarchy of highly 
proliferative progenitor cells (104). Thus, since these cells are sloughed from the 
endothelial lining (225), the endothelium can act as its own source of CACs for tissue 
renewal. Furthermore bone marrow (114) and circulating (115) cells expressing the 
endothelial antigen CD31 but lacking the progenitor antigens (e.g. CD34 or cKit) 
have been described as having profound angiogenic potential. Several authors (34, 
114, 115) emphasized a number of important implications for the existence of 
proangioegenic CD31+ endothelial-like cells for cell-mediated angiogenesis: (i) 
CD31+ cells are far more abundant in peripheral blood of adults than progenitor cells, 
indicating CACs may be more numerous than commonly thought (79); (ii) because of 
this high cell frequency, CD31+ cells have the advantage of not requiring ex vivo 
expansion to obtain significant numbers, thus making them a potentially attractive 
therapeutic source of cell therapy for CV disease; (iii) one of these studies (114) 
showed that in bone marrow, CD31 may be a specific single marker identifying 
CACs for angiogenic potential, which, if confirmed, would greatly simplify the 
controversial issues plaguing the CAC field surrounding cell identity.  
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Associations between CACs and CV Disease Risk  
CV disease and CAC number. Some estimates indicate that conventional CV risk 
factors such as hypertension and dyslipidemia explain only ~50% of CV disease cases 
(22), and there has been intense investigation to determine whether novel risk factors 
can be identified as targets for CV disease prevention and treatment. CACs are 
increasingly thought of as one such novel risk factor, and recent research has 
established solid evidence for a relationship between CAC numbers and CV disease 
incidence and risk. For example, the concentration of CACs are independently 
inversely related to endothelial dysfunction in coronary artery disease patients (249). 
CAC number is also related to a number of conventional CV risk factors and CV 
complications, including age (93), composite Framingham risk score (91), obesity 
(137), hypertension/pre-hypertension (136, 255), and glucose intolerance and diabetes 
(52), inflammation (243, 244) and the prothrombotic state (244). CACs are also 
reduced in overt diseases, including coronary artery disease (195), peripheral arterial 
disease (39), arterial calcification (31); abdominal aortic aneurysm (25), heart failure 
(62), and diabetes (56, 57), and atherosclerosis (54).  
One possible mechanistic explanation for reduced cell numbers in these disease 
states is that reserves of CACs within bone marrow and the vessel wall become 
depleted over the normal course of aging (10, 185, 236, 241, 248). It is thought that 
CV and metabolic disease risk factors (e.g. hyperglycemia or hyperlipidemia, which 
will be discussed in detail below) continually damage the vascular endothelium and 
thus create a constant need for CACs, eventually resulting in the depletion of the pool 
of cells available for endothelial regeneration (63, 83, 99, 205, 236).  
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CV disease and CAC function. CV diseases and risk factors are also associated 
with reduced CAC function. Bone marrow transplantation experiments in young and 
old mice indicated an age-related decline in progenitor cell-mediated 
neovascularization (205). Cells from young donors injected into ischemic hindlimbs 
of older mice completely prevented ischemic injury, however cells from older donors 
had no protective effect when injected into the ischemic limbs of young mice. There 
is evidence that CAC number is reduced with age and in the presence of disease due 
to reduced capacity to mobilize cells from their niche in bone marrow and 
vasculature, and also due to depleted reserves (205, 241). Studies have documented 
an association between age and impaired functional aspects of CACs, including 
reduced migratory capacity (93), reduced secretion of cytokines (122), and increased 
apoptotic susceptibility (122). CACs from patients with metabolic and CV diseases 
and/or CV risk factors have exhibited a variety of impaired functional capacities (e.g., 
impaired migratory capacity, neovascularization potential, in vitro angiogenesis, etc.), 
(83, 87, 88, 99, 112, 113, 228).  
Therefore, there is ample correlational evidence supporting a link between CV 
risk factors or overt disease and reduced number and function of CACs. However, 
investigations into the mechanisms underlying these correlations have only recently 
begun to appear in the literature. A summary of the current information relative to the 
known mechanisms of CACs related to CV disease development and pathogenesis 
follows in the next section.  
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Mechanistic Studies Linking CACs and CV Disease 
In the last few years it has become increasingly clear that NO levels in CACs are 
critical for a number of cellular functions (61), and the molecular regulation of NO in 
CACs is somewhat similar to the mechanisms regulating vessel wall endothelial cell 
NO levels. This section will deal with mechanistic aspects of the relationship between 
CACs and CV disease, with particular focus on NO and oxidative stress.  
Nitric oxide. NO is mechanistically involved in a number of CV functions, 
including smooth muscle cell relaxation for vasodilation, inhibition of leukocyte and 
platelet adhesion, and a number of anti-atherogenic biochemical actions (159). Recent 
evidence supports a critical role for NO in CAC-mediated effects on the vascular 
endothelium (61). The first study highlighting the importance of eNOS-derived NO in 
CAC biology showed that eNOS knockout mice had impaired CAC mobilization 
from the bone marrow and reduced CAC-mediated endothelial repair compared to 
wild type mice (4). Heiss et al. recently demonstrated the importance of NO as a 
regulator of human CAC functional capacity (88). These authors first observed that 
CACs from coronary artery disease patients had no detectable levels of eNOS protein 
whereas CACs from controls had substantial eNOS expression. The disease-
associated eNOS deficiency was correlated with substantially impaired VEGF-
stimulated migratory capacity compared to disease-free control subjects. However, 
treatment of CACs from the patient group with a NO donor completely eliminated the 
difference in migratory capacity between the groups, indicating that the disease-
related impairment in CAC function is entirely NO-dependent.  
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What causes the reduced NO production in disease and in the presence of risk factors 
for CV disease? Accumulated oxidative stress insults are generally accepted as a 
principle cause of cellular aging (33, 77). Evidence from vascular endothelial cell 
biology suggests that oxidative stress, i.e., an imbalance between the production of 
reactive oxygen species (ROS) and the capacity for the cellular antioxidant defense 
systems to protect against excessive ROS, could be involved in CAC functional 
decline with aging and in disease states. However, it has only been in the last few 
years that careful examinations of NO- and oxidative stress-related pathways in 
CACs have begun to appear in the published literature. CAC oxidative stress occurs 
as a result of overproduction of ROS by NADPH oxidase, xanthine oxidase, and/or 
mitochondria (61). The principle components of the antioxidant defense system are 
the superoxide dismutase [cytosolic superoxide dismutase 1 (SOD1) and 
mitochondrial superoxide dismutase 2 (SOD2)], which convert superoxide ( O2     ·-
 
) to 
hydrogen peroxide; catalase, which converts hydrogen peroxide to oxygen and water; 
and glutathione peroxidases, which prevent the oxidation of cellular macromolecules 
(e.g. lipids and proteins).  
NADPH oxidase. The pro-oxidant family of enzymes called NADPH oxidases has 
been most widely studied as a source of oxidant stress in cardiovascular tissues. The 
NADPH oxidase (Nox) family consists of 7 homologues, 4 of which are expressed in 
the cardiovascular system (Nox1, Nox2, Nox4, and Nox 5) (123). There is a well-
established role for Nox2 (a.k.a., gp91phox) as the major Nox homologue in vascular 
endothelial cell physiology and pathophysiology (28, 47, 111, 172). In addition, 
gp91phox is expressed and plays an important role in cells with tissue repair functions 
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including fibroblasts, hematopoietic stem cells, and a number of CAC types (17). 
Therefore, this literature review and the work presented in this dissertation focus 
specifically on this Nox isoform and the supporting subunits with which it associates. 
Structurally, the catalytic subunit gp91phox forms a membrane-bound complex with 
the p22phox subunit. Upon activation of intracellular signaling pathways by factors 
such as angiotensin II (and others, discussed below) the p47phox subunit is 
phosphorylated by proline-directed kinases or protein kinase-C (49), resulting in a 
conformational change that facilitates translocation to the membrane from the 
cytosol. Through additional phosphorylation events, the p67phox subunit binds to the 
translocated p47phox, which provides a binding site for the activated small GTPase 
Rac. Complete assembly of this entire subunit complex is required for activation of 
the enzyme. Once assembled, O2     ·-
 
 is generated via the transfer of electrons from 
NADPH to molecular oxygen. Low levels of NADPH oxidase activity produce O2     ·-
 
 
in controlled amounts, and under normal physiological conditions gp91phox-
derived O2     ·-
 
 can act as signaling molecules for a number of biological processes, 
including angiogenesis (218), endothelium-dependent vasodilation (18), mobilization 
of CACs (223), and the functional responsiveness of CACs to growth factors (226). 
However, when produced in excess, NADPH oxidase-derived O2     ·-
 
 damages cellular 
components, and can interact with NO to produce peroxynitrite (an extremely reactive 
and potent source of nitro-oxidative damage) (159). NADPH oxidase overproduction 
of O2     ·-
 
 can also cause eNOS enzyme uncoupling, resulting in the production of O2     ·-
 
 
by eNOS itself (159). Several factors associated with the development of CV disease 
have been shown to increase NADPH oxidase activity in endothelial cells and CACs, 
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including oxidized LDL-cholesterol (oxLDL) (74, 135); oxidized fatty acids (29); 
angiotensin II (103); hyperglycemia (50, 242), advanced glycation end products 
(AGEs) (245); and a number of inflammatory cytokines such as C-reactive protein 
(170), TNFα (148), and proinflammatory interleukins (IL)-4 and IL-6 (128). 
Xanthine oxidase. Xanthine oxidase is derived from a posttranscriptional 
modification to the constitutively expressed xanthine dehydrogenase. Both of these 
enzymes oxidize hypoxanthine to xanthine and xanthine to urate. Xanthine 
dehydrogenase uses NAD+ as an electron acceptor, generating NADH (a stable 
product). Xanthine oxidase, on the other hand, uses molecular oxygen as the electron 
acceptor, thereby generating O2     ·-
 
 (142, 145). Xanthine oxidase is expressed in 
vascular endothelial cells and CACs, and excess xanthine oxidase activity has been 
linked to oxidative stress-mediated dysfunction of cardiovascular tissues (130, 145, 
161). It has been suggested that the primary role for endothelial cell xanthine oxidase 
is to recruit and activate immune cells in the inflammatory response to foreign 
pathogens (130, 145). These inflammatory and pro-oxidative pathways are highly 
activated in the injury pathogenesis of atherosclerosis (180), and xanthine oxidase 
activity is an important player in the oxidative stress-related development of CV 
disease and atherosclerosis. For example, increased xanthine oxidase activity was 
demonstrated to be partly responsible for hypertension and increased arteriolar tone in 
rats (208). Additionally, coronary artery disease patients displayed increases in 
xanthine oxidase activity in coronary artery endothelial cells compared to controls 
(202). It is important to mention that although the different sources of O2     ·-
 
 discussed 
in this chapter are presented and discussed in isolation, these pro-oxidant enzymes 
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operate in coordinated, tightly controlled networks. This is particularly evidenced by 
the finding that xanthine oxidase-derived O2     ·-
 
 production was completely prevented 
in endothelial cells lacking the NADPH oxidase subunit p47phox (143), suggesting that 
fully assembled and activated NADPH oxidase enzymatic activity is required for 
xanthine oxidase to produce O2     ·-
 
. Finally, all of the studies discussed above have 
examined xanthine oxidase in endothelial cells of the vascular system. The only study 
available that has examined a role for xanthine oxidase in cells with CAC functional 
capacity found that xanthine oxidase-derived O2     ·-
 
 stimulated proliferation of bone 
marrow progenitor cells (169). However, it remains to be determined whether 
excessive xanthine oxidase activity is involved in dysfunctional CACs in the setting 
of CV disease.  
Mitochondrial respiration. Similar to the situations described above for O2     ·-
 
 
derived from NADPH oxidase and xanthine oxidase, O2     ·-
 
 generated as a byproduct 
of cellular respiration acts as a signaling molecule with normal physiological 
functions when produced in a controlled fashion and in low amounts (45). O2     ·-
 
 is 
constitutively generated by complexes I and III of the mitochondrial electron 
transport chain (134, 154). However, here again O2     ·-
 
 in excess is associated with 
cellular damage resulting in negative CV health consequences. In atherosclerosis, 
mitochondria-derived O2     ·-
 
 production has been implicated in the processes of 
monocyte infiltration and their eventual transformation into lipid-laden macrophages 
(i.e., foam cells) (119). The accumulation of these cells at sites of endothelial damage 
(i.e., the atherosclerotic plaques) creates a pro-inflammatory and pro-oxidative 
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microenvironment. Surprisingly, no data are available to assess the role of 
mitochondria derived O2     ·-
 
 in CAC physiology or pathophysiology.  
Antioxidant defenses. Antioxidants are defined as compounds or enzymes that are 
able to compete with oxidizable cellular substrates, and, thus, can prevent or delay the 
oxidation of those substrates (45). The enzymatic antioxidants are cytosolic SOD 
(SOD1), mitochondrial SOD (SOD2), catalase, and glutathione peroxidases. Both 
forms of SOD convert O2     ·-
 
 to hydrogen peroxide and are critical to maintaining an 
appropriate level of intracellular O2     ·-
 
. Catalase, which converts hydrogen peroxide to 
oxygen and water, and glutathione peroxidases, which prevent the oxidation of 
cellular macromolecules (e.g. lipids and proteins), catalyze the conversion of 
hydrogen peroxide (H2O2) generated by SOD activity to water and stable O2 (45). 
Thus, adequate activities of these enzymes are required to prevent the decomposition 
of SOD-derived H2O2 to highly reactive oxygen radicals (e.g., the hydroxyl radical). 
CACs have been noted for their high levels of antioxidant gene expression, and this 
unique feature of CAC biology has been proposed as an explanation for how CACs 
are able to perform their reparative functions in hostile proinflammatory, pro-
oxidative microenvironments [e.g., in areas of damaged endothelium or developing 
atherosclerotic plaque (40, 82)]. There is some, but insufficient, evidence that CAC 
expression and activity of antioxidant genes are responsive to prolonged oxidant 
exposure from the environment. For example, previous work has documented 
declines in intracellular antioxidant functions in CACs with age (81) and upon 
experimental exposure to glycation end products (30). However, whether the 
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antioxidant defense system is altered with lifestyle factors or disease risk factors 
requires additional study.   
Relation of Lifestyle Factors to CAC Number and Function 
Hyperglycemia and CACs. Insulin resistance and diabetes impair CAC-induced 
endothelial regeneration (24, 35, 112). Abnormally high blood glucose concentrations 
damage peripheral tissues by promoting formation of advanced glycation end 
products (AGEs) upon reaction of glucose and other sugars derived from glucose with 
components (primarily proteins) in the circulation and the intracellular environment 
of target tissues (68). Glycated proteins in the blood can bind to a number of AGE 
receptors (rAGEs) on target tissues, and rAGE signaling induces a number of 
oxidative stress pathways (68). In CACs, AGEs have been well documented to impair 
pro-angiogenic functions (30, 187, 206). In addition, excessive glucose (246) and 
AGEs have been shown to activate NADPH oxidase activity (177, 245). 
Mechanistically, p47phox was implicated as a factor in diabetes-related impairments in 
NO levels and in vivo regenerative capacity of CACs, as p47phox RNA interference 
restored the levels of NO and in vivo regenerative capacity of CACs to those of 
healthy controls (200). However, the role of NO depends on the source in diabetes, as 
iNOS-derived, but not eNOS-derived, NO was responsible for increased peroxynitrite 
production in a mouse model of diabetic retinopathy (50). Overall, there is sufficient 
evidence to conclude that a hyperglycemic environment induces substantial oxidative 
stress and angiogenic dysfunction in CACs.  
High-fat diet and CACs. Consumption of high-fat diet is linked to a number of 
CV risk factors, including hyperlipidemia, hypertension, obesity, and metabolic 
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syndrome. Mechanistically, consumption of a high-fat diet induces oxidant stress in 
the vasculature and causes endothelial dysfunction (51, 65, 117). A single high-fat 
meal induces a severe challenge to the vascular endothelium. Flow-dependent 
vasodilation in large conduit vessels was decreased by ~50% at 2-4 hrs following the 
ingestion of a high-fat meal (237). Supplementation with dietary antioxidants in the 
form of vitamins (165) and phytonutrients (a mix of vegetable juice concentrate and 
herbal extracts) were later shown to blunt the effect of high-fat feeding on endothelial 
dysfunction (166), consistent with a role for oxidative stress as a mechanistic 
mediator of the endothelial impairment. Only one study has indirectly assessed the 
effect of a high-fat meal on oxidative stress and functional aspects of CACs. Liu et al. 
(132) investigated the effect of postprandial remnant-like particles (i.e., particles of 
chylomycrons and very low-density lipoproteins with known roles in vascular 
inflammation, oxidative stress and endothelial function) on CACs. CACs exposed to 
remnant lipoprotein particles exhibited impaired migratory and proliferative 
capacities and increased senescence compared to untreated cells. Nitrotyrosine 
staining was increased in remnant like particle-treated cells, and this was inhibited by 
pre-treatment with SOD, suggesting increased O2     ·-
 
 production and formation of 
peroxynitrite as a mechanism of the postprandial remnant-like particle effects on 
CAC function. This study indicates that remnant microparticles, which are elevated 
during the postprandial period following a high-fat meal, induce oxidant stress in 
CACs that could contribute to CV disease-associated impairments in CAC function. 
A limitation of this study (132) was that the remnant like particles were isolated from 
plasma from older hypelipidemic subjects, and the CACs were isolated from young 
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healthy donors. Therefore, the extent to which the results of Liu et al. can be 
extrapolated to the in vivo situation is not clear.  
However, while further evidence is clearly needed with respect to CACs per se, 
there is a growing literature on the effects of a high-fat meal on lipid uptake as well as 
inflammatory- and oxidative stress-pathways in PBMCs (without further division into 
subfractions). Postprandial lipemia (PPL), i.e. the appearance of elevated blood lipids 
following ingestion of a meal, has been repeatedly shown to induce lipid uptake (71, 
127) and activate inflammatory pathways (5, 101, 233) in mononuclear cell 
populations. Mechanistically, it was recently shown that a high-fat meal increases 
expression of the receptor for apoloprotein B-48 in circulating CD14+ monocytes, 
which causes lipid engorgement and foam cell formation in resident macrophages 
(235). Monocytes also upregulate expression of CD11c/CD18, an integrin involved in 
monocyte adhesion to inflamed endothelium and thought to be critical in the in the 
accumulation of monocytes/macrophages in atherosclerotic plaques (252), in 
response to a high-fat meal (71). All of these studies implicated a role for 
inflammatory pathways in the effects of high-fat feeding on circulating monocytes; 
however, oxidative stress pathways have not been adequately examined. Only two 
studies have investigated whether oxidant status was altered in circulating cells 
during PPL. First, it was observed that ingestion of red wine completely prevented 
PPL-induced increases in nuclear factor-kappaB activation in PBMCs, an effect that 
was attributed to its antioxidant properties (19). Second, treatment of cells isolated in 
the postprandial state with the oxidative scavenger dimethylthiourea reduced the 
expression of neutrophil adhesion molecule CD66b by ~35% (5). Thus, there is 
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limited, but promising, evidence that oxidant stress pathways are at least partly 
responsible for dysfunctional proatherogenic effects of a high-fat meal on circulating 
cells. Furthermore, it can be cautiously speculated that similar effects would be 
observed in CACs. Given the roles of (i) CACs in maintaining vascular endothelial 
homeostasis, (ii) oxidative stress in CV disease- and risk factor-related CAC 
dysfunction, and (iii) postprandial lipemia in the development of endothelial 
dysfunction and atherosclerosis, it would appear that studies investigating the effects 
of high-fat feeding on oxidant stress in CACs are urgently needed. 
Effects of acute exercise on CAC number. Acute exercise increases the number of 
CACs in most (124, 146, 152, 174, 193, 212, 214, 228, 231, 257) but not all (133, 
212) studies. A number of factors appear to determine whether CAC numbers 
increase with exercise. For example, age, training status, and the nature of the 
exercise stimulus appear to play a role (149, 152, 212). Particularly, exercise intensity 
(124, 152, 231) and/or duration (124, 146) must be sufficient. In one study 
investigating the effects of prolonged endurance exercise (i.e., a marathon), there was 
no change in CACs defined as CD34+/VEGFR2+ cells (2). However, there was a 
significant decrease in CD34+ progenitors, and therefore an increase in the percentage 
of endothelial antigen-expressing cells within the total CD34+ cell pool. The authors 
interpreted these findings as evidence that prolonged running exercise may induce 
endothelial differentiation of circulating progenitors. Recently, Bonsignore et al. (21) 
published a comprehensive comparison of the effects of short-duration maximal 
exercise (a 1500m run) and prolonged endurance exercise (a marathon) on three 
different types of CACs (CD34+/VEGFR2+ EPCs, CD133+/VE-cadherin+ EPCs, and 
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cultured CACs derived from the whole PBMC pool). Levels of all three cell types 
increased significantly with both types of exercise. However, the magnitude of the 
increase in CD133+/VE-cadherin+ EPCs was greater with marathon running compared 
to the 1500m run. In contrast, the number of CACs generated by the culture assay 
was induced to a greater extent by the 1500m run than the marathon, and the increase 
in CD34+/VEGFR2+ cells did not differ between exercise bouts. In addition, the total 
numbers of CD34+ or CD133+ progenitor cells were unchanged with prolonged 
endurance exercise. Together, these data indicate that the effect of acute exercise on 
CAC number varies according to intensity and duration and differs among CAC 
subpopulations. 
In terms of molecular regulation of exercise-induced CAC mobilization, the 
relatively rapid increase in circulating VEGF levels with acute exercise has recently 
been proposed to act as a stimulus for mobilization of CACs (146). Morici et al. (152) 
observed increases in CD34+ and CD133+ progenitors in response to supramaximal 
interval rowing exercise, and these changes were tightly linked with increases in 
levels of a number of circulating stem cell-mobilizing factors. These data suggest a 
possible role for cytokines in exercise-induced mobilization of progenitor cells from 
the bone marrow. Another important mechanism for exercise-induced CAC 
mobilization is NOS activity, as a recent study indicated that a significant effect of 
acute exercise on CAC number was completely blunted by infusion of the NOS 
inhibitor L-NAME (36). This finding was consistent with the previously-established 




Effects of acute exercise on CAC function. Few data are available on the effects of 
acute exercise on functional aspects of CACs. Acute exercise reversed CAC 
dysfunction in heart failure patients (228), although this acute exercise effect was not 
observed by the same research group following a period of exercise training (230). It 
can be speculated that an increase in CAC intracellular NO levels could be partially 
responsible for the acute exercise-induced improvement in CAC, as a previous study 
indicated that exercise increased NO release by CACs into their culture media (257). 
In addition, our laboratory also recently found that acute exercise may influence the 
function of CACs by favorably influencing cell cycle gene expression through 
thrombin signaling (133), suggesting a possible role for thrombin in CAC-mediated 
endothelial maintenance.  
Effects of chronic exercise on CAC number. The first report of exercise training-
induced effects on CACs indicated that mice with access to a running wheel had 
higher circulating levels of spleen- and bone marrow-derived CACs than sedentary 
mice (125). There is evidence that oxidant stress is involved in the regulation of 
chronic exercise-induced changes in CAC number, as experimental knockdown of 
catalase activity in mice prevented increases in bone marrow CACs following a 3-wk 
period of physical activity (207). In humans, most investigations of the effects of 
exercise training on CACs have used CV disease patients as study participants. From 
these studies, it appears that patients with CV risk factors or overt CV disease 
increase CAC number with regular exercise (1, 125, 181, 203, 230). Healthy patients 
can also increase CAC number following exercise training (93). Cross-sectional 
studies of healthy subjects have been less supportive of chronic exercise effects on 
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baseline CAC number (133, 212, 251), although there has been one report of higher 
CD34+ cells in trained than in sedentary older men (212). We found that the changes 
in CD34+ and CD34+/VEGFR2+ cell numbers were closely related to changes in total 
antioxidant capacity and endothelial function during detraining in master’s athletes 
(251), suggesting that maintenance of CAC number through regular physical activity 
may be an important mechanism by which regular exercise functions to preserve 
vascular endothelial health.  
Effects of chronic exercise on CAC function. The first study investigating the 
effects of exercise on CACs by Laufs et al. found not only an increase in the number 
of CACs in both mice and humans, but also a correlation between the change in CAC 
number and the extent of neovascularization in the trained mice (125). Although this 
study is often interpreted as evidence for the involvement of CACs in training-
induced angiogenesis [for example, in the recent review by Mobius-Winkler et al. 
(147)], the data were correlative and indirect. The best evidence supporting a role for 
CACs in exercise training-induced neovascularization came from a study in which 
mice were subjected to an experimental stroke (67), and greater numbers of 
genetically-labeled bone marrow cells were found in revascularized brain regions of 
animals with access to running wheels compared to animals who remained sedentary 
following stroke. Thus, bone-marrow derived CACs may play a role in exercise 
training-induced angiogenesis of ischemic tissues in CV disease, but clearly these 
data need confirmation in human subjects. In addition, while few studies have 
investigated endurance training effects on human CAC function, longitudinal data 
indicate that training can enhance migration of CACs towards angiogenic growth 
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factors (93). There is also evidence that proliferative capacity and/or endothelial-
directed differentiation of CACs may be altered by regular exercise. Our laboratory 
found higher levels of endothelial gene expression in CACs from trained compared to 
sedentary individuals (133). Somewhat different from our finding of increased CAC 
differentiation towards the endothelial lineage, treatment of CACs with serum from 
subjects following an exercise training program significantly increased proliferative 
capacity of CACs (66). 
Summary of Literature Review 
Overall, there is sufficient evidence in the literature to state the following as facts: 
(i) CACs do exist and they play an important role in the maintenance of vascular 
endothelial integrity; (ii) NO and oxidative stress are mechanistic mediators of CAC 
number and function, and (iii) the number of CACs is increased by acute and chronic  
endurance exercise. Priorities for advancing the CAC field include the examination of 
whether and how acute and/or chronic exercise modifies functional aspects of CACs 
by altering NO- and oxidative stress-related processes. Integrative studies examining 
the interactive effects of physical activity and dietary factors on associated with 
oxidant status of CACs are especially needed. Thus, clearly much work remains for 
future studies to further clarify the role of CACs in acute and chronic exercise effects 




Chapter 3: Effects of Acute and Chronic Endurance Exercise on Intracellular 
Nitric Oxide in Putative Endothelial Progenitor Cells: Role of NADPH Oxidase 
 
The following is a reprint of the report of this study as it was published previously:  
 
Jenkins et al., American Journal of Physiology – Heart and Circulatory Physiology 
297(3): H1798-H1805, 2009. 
 
Included with permission from the American Physiological Society (see Appendix). 
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We sought to delineate the effects of acute and chronic exercise on the regulation of 
intracellular nitric oxide (NOi) production in putative endothelial progenitor cells 
(EPCs).  Putative EPC colony forming units (CFU-EC) were cultured from blood 
drawn before and after 30 min of treadmill exercise at 75% of maximal oxygen 
uptake in active (n = 8) and inactive (n = 8) men.  CFU-EC were similar between 
groups at baseline, but increased after exercise in active men only (P = 0.04).  CFU-
EC expressed lower NADPH oxidase subunit gp91phox mRNA and elevated 
endothelial nitric oxide synthase (eNOS) mRNA in active relative to inactive men at 
baseline (P < 0.05).  Acute exercise reduced gp91phox mRNA in CFU-EC of both 
groups (P < 0.05), while p47phox mRNA levels were reduced in the inactive group 
only (P = 0.02).  There were no differences between groups or with acute exercise in 
xanthine oxidase, superoxide dismutase (SOD) isoforms, or gluthathione peroxidase-
1 (GPX-1) mRNA levels. NOi was significantly greater in CFU-EC of active men at 
baseline (P = 0.004).  NOi increased in CFU-EC of inactive men with acute exercise, 
and in vitro experiments with apocynin indicated the increased NOi production was 
caused by suppression of NADPH oxidase.  However, the increases in NOi with the 
different treatments in the inactive group did not reach the baseline levels in the 
active group (P < 0.05).  We conclude that acute exercise increases NOi in cells 
generated by the CFU-EC assay through an NADPH oxidase-inhibition mechanism in 
sedentary men.  However, differences due to chronic exercise must involve additional 
factors.  Our findings support exercise as a means to improve putative EPC function 








Bone marrow-derived progenitor cells with vasculogenic capacity, often termed 
putative endothelial progenitor cells (EPCs), have emerged as a novel cardiovascular 
(CV) disease risk factor because of their role in the maintenance of vascular 
endothelial integrity.  Circulating levels of putative EPCs independently predict CV 
disease progression, CV events, and endothelial dysfunction (189, 248) and EPC 
number and function decline with physical inactivity (211).  Thus, the available data 
strongly implicate putative EPCs as potential targets in the primary prevention of CV 
disease through regular exercise. 
Acute and chronic endurance exercise are thought to increase EPC number and 
their ability to secrete pro-angiogenic growth factors and/or incorporate into existing 
vascular endothelium (190, 211).  A single exercise bout increases putative EPC 
number in humans (37), and exercise training interventions have increased putative 
EPC number and colony forming units (CFU-EC) in healthy subjects (93), and, most 
frequently, in patients with CV disease risk factors or overt CV pathologies (125, 131, 
162, 203).  However, while these previous studies provided strong evidence of 
putative EPC involvement in the exercise-induced enhancements of vascular health, 
the data are generally associative and mechanistic cause-effect relationships have not 
been established. 
The signaling molecule nitric oxide (NO) plays a central role in the function of 
EPCs (216), as well as in mature endothelial cells (ECs) (159).  Exercise training 
improves endothelial function by increasing vasodilatory NO release and endothelial 
nitric oxide synthase (eNOS) activity in ECs (125).  Conversely, NO activity is 
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markedly reduced in the presence of CV disease risk factors including sedentary 
behavior (138).  Physical inactivity causes endothelial dysfunction in part through 
impairment of eNOS (256) by upregulation of the pro-oxidant enzyme NADPH 
oxidase (138, 161), which generates deleterious superoxide anions and, via 
uncoupling of the eNOS reaction, the powerful oxidant peroxynitrite (118, 161).  
NADPH oxidase is one of the most important sources of oxidative stress in mature 
ECs throughout the CV system (159), and although the available evidence indicates 
that the eNOS and NADPH oxidase pathways are active in putative EPCs (48, 258), 
they have not been adequately characterized with respect to alteration of putative EPC 
function by physical activity.  It is plausible that a reduction in NO generation by 
increased NADPH oxidase activity is a cellular mechanism for impaired putative EPC 
function with a sedentary lifestyle. 
Therefore, the purpose of this study was to determine the effects of acute and 
chronic endurance exercise on the intracellular environment of putative EPCs.  We 
hypothesized that acute exercise and regular physical activity would increase CFU-
EC intracellular NO (NOi) levels by upregulation of eNOS and suppression of 
NADPH oxidase.  We also explored whether mRNA levels of other pro-oxidant 
(xanthine oxidase) and antioxidant [copper-zinc and manganese superoxide 
dismutases (CuZnSOD and MnSOD, respectively), and glutathione peroxidase-1 





All participants were young, healthy, nonsmoking males with no history of CV or 
metabolic disease, and were not taking prescription medications.  The active group (n 
= 8) consisted of men age 18-30 yrs with a history of >3 yrs moderate- to high-
intensity endurance exercise for >4 hrs/wk.  These men were recruited from local 
running clubs in the University of Maryland area.  The inactive group (n = 8) 
included young men of a similar age who reported ≤20 min endurance exercise ≤2 
days/wk.  Groups were matched for age, body mass index (BMI), body composition, 
and conventional CV risk factor profile.  All participants provided written informed 
consent prior to all testing and the University of Maryland Institutional Review Board 
approved all study procedures.   
Maximal graded exercise test and body composition 
All testing occurred in the morning after an overnight fast and refraining from 
alcohol, vitamins, and caffeine for 24 hrs.  Height, weight, and blood pressure were 
measured, and body fatness was estimated using the seven-site skinfold procedure 
(107).  Maximal oxygen uptake (V
 .
O2max) was assessed using a constant-speed 
treadmill protocol with 2% increases in incline every 2 min until exhaustion.  The 
treadmill speed was chosen by the investigators based on subject experience, typical 
running speed, and heart rate such that V
 .
O2max was achieved in ~6-12 min.  Expired 
gases were analyzed using an automated indirect calorimetry system (Oxycon Pro, 
Cardinal Health, Inc.; Dublin, OH). V
 .
O2 was considered maximal using the plateau 
criteria, and all tests met at least two of the following secondary criteria of maximal 
effort: a respiratory exchange ratio of >1.10, a rating of perceived exertion of ≥19, 
and/or a peak heart rate within 10 beats per minute of the age-predicted maximum 
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(6).  Heart rate was measured during testing using heart rate monitors (Polar Electro, 
Inc.; Woodbury, NY).   
Blood sampling and steady state exercise test  
Participants reported to the laboratory after an overnight fast for experimental 
testing 48-72 hrs after completing the V
 .
O2max and body composition assessments.  A 
blood sample for baseline CFU-EC and standard CV risk factor assessments was 
drawn immediately before exercise, and a second sample was obtained for CFU-EC 
30 min after completing a 30-min treadmill run at 75-80% V
 .
O2max.  Treadmill 
running speed was the same as that used for the  V
 .
O2max test and the appropriate 
percent incline was estimated from the American College of Sports Medicine 
equation for V
 .
O2 during treadmill running (6).  Intensity during exercise was 
monitored using the heart rate reserve method. 
Colony forming unit-endothelial cell (CFU-EC) assay  
The CFU-EC assay was performed as described previously (91).  Briefly, 
mononuclear cells were isolated from peripheral blood samples obtained before and 
30 min after exercise by density gradient centrifugation (Ficoll Paque Plus, GE 
Healthcare; United Kingdom).  The cells were washed twice with PBS supplemented 
with 2% FBS, and plated at 5 × 106 cells/well on 6-well culture plates coated with 
human fibronectin (BD Pharmingen; Franklin Lakes, NJ) in 2 mL Endocult Medium 
(Stem Cell Technologies; Vancouver, BC).  Non-adherent cells were harvested after a 
48-hr incubation in a humidified incubator (37C, 5% CO2) and replated (1 × 106 
cells/well) on 24-well fibronectin-coated plates (BD-Pharmingen) in 1 ml Endocult 
Medium.  CFU-EC appeared 3d later and were defined according to previously 
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established methodology which includes central cores of round cells with more 
elongated sprouting cells at the periphery (91).  The endothelial lineage of these cells 
has been confirmed previously by immunocytochemical staining for von Willebrand 
factor, vascular endothelial growth factor receptor-2, and CD31 (91).  Investigators 
trained in identification of colonies but blind to the status of the sample performed 
CFU-EC counts in four randomly chosen wells.  The correlation between observers in 
our laboratory for CFU-EC counts was 0.98 (p < 0.001).  To reduce assay variability, 
all experiments in this study were performed with the same stock and lot of Endocult 
basal medium and supplements.   
Gene expression by semiquantitative RT-PCR 
eNOS, NADPH oxidase (subunits gp91phox, p47phox, and p67phox), xanthine 
oxidase, CuZnSOD, MnSOD, and GPX-1 mRNA levels were measured using 
semiquantitative RT-PCR.  Total RNA was extracted in quadruplicate from CFU-EC 
cultured for 5 days using the TRI reagent (Sigma-Aldrich; St. Louis, MO) according 
to previously described methods (201).  RNA quantity was calculated from 
absorbance at 260 nm and quality was verified by the 260:280 absorbance ratio.  
RNA was reverse transcribed to cDNA using the High Capacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Inc.; Carlsbad, CA) according to the 
manufacturer’s instructions.  cDNA was amplified using specific primers under 
optimal thermal cycling conditions determined empirically for each target gene as 
previously described (201).  The primer sequences and thermal cycling conditions are 
presented in Table 2.  PCR products were separated by agarose gel electrophoresis 
and photographed under ultraviolet light.  Signal intensities were semi-quantified 
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using NIH imaging software (ImageJ) and normalized to the signal for the reference 
gene 18S.   
Experimental blockade of NADPH oxidase activity  
NADPH oxidase activity in CFU-EC was inhibited using the drug apocynin 
(Sigma-Aldrich) in ex vivo experiments to determine if exercise increases CFU-EC 
NOi via an NADPH oxidase-dependent mechanism.  Apocynin prevents assembly of 
the enzyme by reacting with thiol groups required for the translocation of the 
intracellular subunits p47phox and p67phox to the catalytic gp91phox subunit, in turn 
preventing the generation of deleterious superoxide radicals (204).  Cells of active 
and inactive groups from before and after acute exercise were incubated from day 4 to 
day 5 of the CFU-EC assay with 100 μM apocynin in 1 ml Endocult medium.  Cells 
treated with the same volume of the apocynin vehicle (10 µl PBS) in 1 ml Endocult 
medium were used as a control.  The apocynin concentration and the 24-hr treatment 
were empirically determined to produce detectable changes in NOi.  We aimed to not 
affect the early events of the assay such as adherence of the cells to the plate or initial 
differentiation into CFUs, but we did want to allow sufficient time for any measurable 
effects of apocynin on NOi to appear. An apocynin-induced increase in endothelium-
dependent dilation and its NO component in mouse aorta was recently observed in as 
little as 60 min (46).  Therefore, we believe the 24-hr experiment was valid for our 
purposes.  The experiment consisted of the following conditions for both active and 
inactive group CFU-EC: baseline-vehicle (BL-VEH), baseline-apocynin (BL-APO), 
exercise-vehicle (EX-VEH), and exercise-apocynin (EX-APO).  These experiments 
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were performed on CFU-EC from a subset of individuals (n = 3-5 per group per 
condition). 
Detection of intracellular nitric oxide in CFU-EC   
NOi was measured using the DAF-FM diacetate fluorescent dye technique  
(Molecular Probes, Carlsbad, CA) as described by Drenning et al. (44), with minor 
modifications.  DAF-FM diacetate is a pH-insensitive dye that emits fluorescence on 
reacting with an intermediate of NO during the spontaneous oxidation of NO to NO2
-.  
On day 5 of the CFU-EC assay, media were removed, CFU-EC in triplicate wells 
were washed twice with 500 µl PBS, loaded with 500 µl PBS containing 10 μM 
DAF-FM diacetate, and incubated for 30 min at 37°C.  Dyed cells were washed twice 
with PBS, and NOi fluorescence was measured using a multi-label plate reader 
(Wallac 1400 VICTOR2, Perkin Elmer, Inc., Waltham, MA) with excitation and 
emission wavelengths of 488 and 535 nm, respectively.  Every CFU-EC plate 
included the following controls: (i) duplicate wells of unloaded cells to serve as a 
control for cellular autofluorescence, (ii) duplicate wells that contained no cells, but 
contained 10 µM DAF-FM in PBS to correct for any fluorescence resulting from the 
dye itself, and (iii) duplicate wells of 500 µl PBS alone.  As the arbitrary-type 
fluorescence among these three control conditions were similar in pilot experiments 
(P = 0.7, data not shown), the average fluorescence value of the three controls was 
subtracted from each experimental value.  The average within- and between-assay 
coefficients of variation for the arbitrary fluorescence were 5% and 9%, respectively, 
indicating good agreement in arbitrary fluorescence between wells on the same plate 
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and among experiments conducted on different days.  Data are expressed as fold 
difference from the mean for the active group's CFU-EC in the BL-VEH condition.   
In addition, we must point out that gene expression and NOi measurements were 
made on all cells present in the CFU-EC assay, and not the colonies alone. Thus, the 
term "CFU-EC" must be interpreted to mean all cells cultured in the CFU-EC assay 
when we refer to our NOi and gene expression data.  
Statistics 
Between-group and acute exercise effects were analyzed by independent and 
paired samples t-tests, respectively, according to a priori planned contrasts.  Within- 
and between-group ANOVA with Dunnett’s post hoc tests were used to determine 
whether exercise and/or apocynin treatments increased NOi relative to BL-VEH.  We 
used the α = 0.05 criterion for statistical significance.  Data are presented as mean ± 
SE unless indicated otherwise.   
RESULTS 
Active and inactive participants were successfully matched on the basis of age, 
BMI, and the standard CV risk factor profile, but differed significantly in terms of V
 .
O2max (Table 1).    
CFU-EC counts 
CFU-EC counts were not different between groups at baseline (P = 0.23; Figure 
3.1A).   CFU-EC increased after exercise in the active group (P = 0.02), but did not 




eNOS mRNA levels were elevated in CFU-EC from active relative to inactive 
men by ~30% at baseline  (P = 0.04) and by ~17% after exercise (P = 0.05), but did 
not change with exercise in either group (P ≈ 0.4 for exercise-induced changes in both 
groups) (Figure 3.2).  gp91phox mRNA levels were ~44% lower in CFU-EC from 
active than inactive men at baseline (P = 0.02) and were reduced after acute exercise 
in both groups (active, P = 0.02; inactive, P = 0.04), with expression remaining 
significantly (P = 0.01) higher after exercise in CFU-EC of inactive compared to 
active men (Figure 3.3A).  p47phox mRNA levels did not differ between groups at 
baseline but decreased by ~20% after exercise in the inactive group (P = 0.02) (Figure 
3.3B).  There were no differences between groups or with acute exercise in p67phox 
mRNA levels (Figure 3.3C) or xanthine oxidase (Figure 3D) mRNA levels (P > 
0.05).  There were also no differences between groups or with acute exercise in 
expression of the antioxidant genes CuZnSOD, MnSOD, or GPX-1 (Figure 3.4A-C; P 
> 0.05). 
Intracellular nitric oxide (NOi)  
Detectable NOi was ~56% greater in the cells cultured in the CFU-EC assay from 
active compared to inactive men (p = 0.004) (Figure 3.5).  In the active group there 
were no significant differences among BL-VEH, BL-APO, EX-VEH, or EX-APO in 
CFU-EC NOi (ANOVA P > 0.05).  In the inactive group, BL-APO (P = 0.04), EX-
VEH (P = 0.04), and EX-APO (P = 0.02) all significantly increased NOi levels 
relative to the BL-VEH condition.  However, there were no differences in NOi among 
these three experimental conditions for the inactive group (all P > 0.05).  
Additionally, inactive group NOi levels were significantly lower compared to the 
 43 
 
active group BL-VEH in all experimental conditions (BL-APO, EX-VEH, and EX-
APO; all P < 0.05).  Colony formation was not affected by VEH or APO treatments 
(data not shown); therefore, CFU-EC count data are from VEH or untreated samples. 
DISCUSSION 
The main findings of this study are (i) acute exercise increases CFU-EC NOi 
levels in sedentary individuals, (ii) regular endurance exercise is associated with 
increased eNOS gene expression and NOi in CFU-EC, (iii) the acute exercise effect 
on NOi is NADPH oxidase-dependent, and (iv) the training effect on NOi appears to 
involve other mechanisms besides reduced NADPH oxidase activity.  Importantly, 
these differences were observed between groups of healthy young men who were 
matched for age, BMI, and the standard CV risk factor profile, and differed only in V
 .
O2max.  Our findings support the notion that acute and chronic exercise improve 
putative EPC function and suggest a novel cellular mechanism that may explain this 
effect.  
NADPH oxidase is regarded as one of the most important sources of oxidative 
stress in the CV system (78, 159, 161).  ECs throughout the CV system express 
elevated NADPH oxidase in several pathological conditions associated with physical 
inactivity, including CV disease (3), hypertension (111), and diabetes (155).  In 
putative EPCs, excessive NADPH oxidase-derived superoxide radicals promote 
premature cellular senescence and reduced proliferative capacity (103).  Here, we 
show elevated expression of the NADPH oxidase catalytic subunit gp91phox gene in 
CFU-EC of healthy men who would be considered very healthy, and have excellent 
CV disease risk profiles, but who do not regularly perform endurance exercise.  We 
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show further that a single bout of exercise reduces mRNA expression of gp91phox and 
p47phox in CFU-EC NOi from these men.  To our knowledge, no studies have assessed 
the effects of acute or chronic endurance exercise on putative EPC NADPH oxidase 
gene expression, but these data are consistent with a previous report of CV disease 
patients showing a reduction in gp91phox mRNA in coronary artery ECs following a 4-
wk endurance training program (3).   
Because eNOS uncoupling, and subsequent depletion of NOi, is a consequence of 
elevated NADPH oxidase activity (118, 161), we tested whether the observed 
differences in eNOS and NADPH oxidase gene expression between groups and with 
acute exercise were corroborated by differences in CFU-EC NOi.  Consistent with the 
elevated baseline gp91phox and reduced eNOS mRNA levels in the inactive group, 
these individuals also displayed significantly lower NOi compared to the active group.  
The inactive group NOi levels increased with BL-APO, EX-VEH, and EX-APO 
treatments.  Importantly, the effects of NADPH oxidase inhibition and acute exercise 
on NOi were nearly identical in magnitude and were not additive, as evidenced by no 
further increase in NOi in the EX-APO condition over either treatment alone.  
Further, there was no acute exercise effect on eNOS mRNA in either group, despite a 
between-group difference at baseline.  Together, these data indicate that in inactive 
individuals, NOi in putative EPCs is increased by acute endurance exercise through 
an NADPH oxidase-driven mechanism.  This is a critical finding of the study, but this 
mechanism only partly explains the training-related differences in NOi in cells of the 
CFU-EC assay.  The increases in the inactive group's NOi by apocynin, exercise, and 
their combination were not sufficient to reach the levels of the active group's CFU-EC 
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NOi under the BL-VEH condition.  Thus, the exercise training-induced difference in 
NOi is also likely explainable by the elevated baseline eNOS gene expression in the 
active group as well as other mechanisms independent from NADPH oxidase. 
The changes observed with acute exercise in the inactive group were not observed 
in the active group.  CFU-EC of these individuals displayed lower gp91phox mRNA at 
baseline and decreased expression of gp91phox following exercise, but this change was 
apparently without consequence for NOi levels, which remained higher in CFU-EC 
from active men under all experimental conditions.  It is reasonable to speculate that 
we have observed a ceiling effect for the active individuals' NOi levels. 
Most reports of acute exercise and exercise training effects on putative EPCs have 
enumerated cells by colony-forming potential in culture or flow cytometry.  In 
general, exercise training increases putative EPC number and colony-forming 
potential (93, 125, 162, 203), but this has not always been the case (212).  The 
available data are also equivocal as to whether an acute exercise bout increases 
putative EPCs, with some studies showing increased EPC number (124, 231) and 
colony formation (70, 124, 174) after acute exercise, but others showing no effect on 
putative EPC number (212) or colony formation (231).  The most consistent effects of 
acute and chronic exercise have been observed in patient populations with overt 
endothelial dysfunction and CV pathologies (125, 162, 203).  Of all these studies, the 
acute exercise CFU-EC data in the present study are most consistent with (i) a report 
in which CFU-EC increased in endurance-trained individuals after exercise of 
equivalent intensity and duration to that in the present study (30 min at ~80% V
 .
O2max) (124), and (ii) another report showing no change in CFU-EC after exercise in 
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a group of untrained, but healthy, men and women (231).  Therefore, taken with 
previous data, the present study suggests a relationship between participant fitness 
and the response of putative EPC colony formation to acute exercise, but this 
hypothesis needs further attention. 
However, the effects of exercise on the EPC intracellular environment may well 
be far more important than acute or chronic exercise effects on putative EPC number 
or colony formation.  From our data, a reasonable working hypothesis is that the 
intracellular environment of a putative EPC may influence its functional capacity and 
its ability to affect endothelial function.  NADPH oxidase and eNOS were chosen as 
target genes in this study because of their well-characterized role in the (dys)function 
of the endothelium throughout the CV system.  Clearly, our evidence suggests that 
NOi production is altered in putative EPCs due to changes in activity, indicating an 
important effect of exercise on the EPC intracellular environment.  Our evidence 
further suggests that an impaired intracellular redox state resulting from high NADPH 
oxidase activity may be detrimental to putative EPC function in young, healthy men 
with a sedentary lifestyle. 
Our findings indicate a role for NADPH oxidase in the regulation of NOi in cells 
generated by the CFU-EC assay.  However, additional factors were implicated in 
training-related differences as well as the response to acute exercise in inactive 
subjects. Thus, we also investigated the expression of other genes involved in 
intracellular redox status.  The findings that mRNA levels of antioxidant (CuZnSOD, 
MnSOD, and GPX-1) and pro-oxidant (xanthine oxidase) genes did not differ 
between groups or with acute exercise support the role for NADPH oxidase as a key 
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mediator of NOi dynamics.  However, these data do not clarify the complete training-
related or acute exercise-induced differences in NOi.  Further work will be necessary 
to fully identify all the factors explaining the differences NOi regulation in putative 
EPCs between the trained vs. untrained states.  We speculate that there may be 
differences in the activities or responsiveness of these or other oxidases or antioxidant 
systems that we did not detect at the mRNA level.  
We must acknowledge three limitations of our study.  First, NOi and gene 
expression were measured from all cells present in the dish, and not the colonies 
themselves.  Fluorescence microscopy experiments have documented eNOS activity 
in cells generated by the CFU-EC assay (158), but the amount of NO release by the 
colonies relative to the other cells present in the dish has not been determined.  
Therefore, it is unclear if differences detected in NOi measures were due to changes 
in NO production in the colonies themselves, or due to changes in a subpopulation of 
cells outside the colonies that express eNOS and/or NADPH oxidase.  However, the 
data of Hill and colleagues (91) suggest that it is the CFU-EC themselves that express 
endothelial markers, and the colonies have been repeatedly shown to take up 
acetylated LDL and bind to lectin, suggesting an endothelial phenotype.  Second, 
there are conflicting reports about the identity of cells generated by the CFU-EC 
assay.  An emerging hypothesis suggests that CFU-EC may be T cells (41) with a 
distinct angiogenic phenotype (100).  There are also very recent data on the existence 
of a novel population of circulating CD31+ T cells that secrete angiogenic growth 
factors (121), which is one mechanism by which CFU-EC have been proposed to 
promote new vessel growth (100, 224).  We believe our data provide new information 
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on how acute and chronic endurance exercise may alter the function of these cells, but 
we must emphasize that the precise identities of these cells and other putative 
vasculogenic progenitors are still being elucidated.  Finally, while it appears likely 
that the effect of acute exercise on NOi was NADPH oxidase-dependent based on our 
study design, we must be somewhat circumspect with this conclusion.  We 
acknowledge that a number of other factors affect NO throughout the CV system 
(159). 
In conclusion, we found a cross-sectional difference between active and inactive 
young men in NOi in cells cultured in the CFU-EC assay that may be partly explained 
by elevated NADPH oxidase with physical inactivity.  Acute exercise appears to 
attenuate some, but not all, of this difference through suppression of NADPH oxidase 
activity, indicating the existence of a training effect that must be due to elevated 
eNOS and other factors.  Our findings may have important implications for the role of 
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(n = 8) 
Inactive 
(n = 8) 
P 
Age (y) 25 ± 4 25 ± 3 0.82 
Height (m) 1.81 ± 0.1 1.81 ± 0.04 0.96 
Weight (kg) 78.8 ± 13.2 77.9 ± 17.2 0.90 
BMI (kg·m-2) 24.0 ± 3.8 23.6 ± 4.4 0.86 
Fat (%) 14.1 ± 5.4 14.8 ± 6.7 0.82 
FFM (kg) 67.3 ± 8.8 65.4 ± 9.6 0.70 
Glucose (mg·dl-1) 84 ± 8 81 ± 8 0.45 
TC (mg·dl-1) 149 ± 21 147 ± 25 0.87 
HDL (mg·dl-1) 53 ± 5 49 ± 11 0.31 
LDL (mg·dl-1) 81 ± 21 81 ± 22 0.99 
TG (mg·dl-1) 70 ± 18 82 ± 30 0.40 
SBP (mm Hg) 118 ± 6 121 ± 5 0.29 












-1·min-1) 70.1 ± 5.1 55.5 ± 4.3 P < 0.001 
*Abbreviations: BMI, body mass index; FFM, fat-free mass; TC, total cholesterol; 
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; 
TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood pressure;  
V
 .





Figure 3.1.  (A) Endothelial cell colony forming units (CFU-EC) in active and inactive
men at baseline and after 30 min exercise at 75% V
 .
O2max.  *Significantly different from
baseline value (P < 0.05).  (B) Acute exercise-induced change in CFU-EC in active and
inactive men.  *Significantly smaller change in inactive than active men (P < 0.05). 
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Figure 3.2.  eNOS mRNA as measured by semiquantitative reverse transcriptase-PCR
in active and inactive men. *Significant difference between groups (P < 0.05). 
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Figure 3.3.  mRNA levels of the NADPH oxidase subunits gp91phox (A), p47phox 
(B), and p67phox (C), and xanthine oxidase (XO).  *Significant difference between 
groups (P < 0.05); †Significant within-group difference (after vs. before acute 




Figure 3.4.  mRNA levels of CuZnSOD (A), MnSOD (B), and GPX-1 (C).  There 
were no significant differences between groups or with acute exercise in either 
group (P > 0.05). 
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 Figure 3.5.  Effects of acute exercise and NADPH oxidase inhibition on 
intracellular nitric oxide (NOi) in CFU-EC from active and inactive men.  Relative 
fluorescence units (RFU) were normalized to the mean for the active group 
baseline-vehicle (BL-VEH) condition.  *Significant difference from within-group 
BL-VEH condition (P < 0.05).  †Significantly different from active group CFU-EC 
under the BL-VEH condition (P < 0.05).
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Chapter 4: Effects of Acute and Chronic Endurance Exercise on Intracellular 
Nitric Oxide and Superoxide in Circulating CD34+ and CD34- Cells 
 
The following is a reprint of the report of this study as it will be published in the 
Journal of Applied Physiology (Epub June 23, 2011). Permission from the American 
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We investigated the influence of acute and chronic endurance exercise on levels 
of intracellular nitric oxide (NO), superoxide ( O2     ·-
 
), and expression of genes 
regulating the balance between these free radicals in CD34+ and CD34- peripheral 
blood mononuclear cells (PBMCs; isolated by immunomagnetic cell separation). 
Blood samples were obtained from age- and body mass index (BMI)-matched 
endurance-trained (n = 10) and sedentary (n = 10) men before and after 30 min of 
exercise at 75% maximal oxygen uptake (V
 .
O2max). Baseline levels of intracellular 
NO (measured by DAF-FM diacetate) and O2     ·-
 
 (measured by dihydroethidium) were 
26% (P < 0.05) and 10% (P < 0.05) higher, respectively, in CD34+ PBMCs from the 
sedentary group compared to the endurance-trained group. CD34+ PBMCs from the 
sedentary group at baseline had 2-fold greater inducible nitric oxide synthase (iNOS) 
mRNA and 50% lower endothelial NOS (eNOS) mRNA levels compared to the 
trained group (P < 0.05). The baseline group difference in O2     ·-
 
 was eliminated by 
acute exercise. Experiments with apocynin indicated that the training-related 
difference in O2     ·-
 
 levels was explained by increased NADPH oxidase activity in the 
sedentary state. mRNA levels of additional angiogenic and antioxidant genes were 
consistent with a more angiogenic profile in CD34+ cells of trained subjects. CD34- 
PBMCs, examined for exploratory purposes, also displayed a more angiogenic 
mRNA profile in trained subjects, with vascular endothelial growth factor (VEGF) 
and eNOS being more highly expressed in trained subjects. Overall, our data suggest 
an association between the sedentary state and increased nitro-oxidative stress in 








CD34+ peripheral blood mononuclear cells (PBMCs) are stem/progenitor cell 
precursors for hematopoietic and endothelial cells (11). Given appropriate 
environmental cues, CD34+ PBMCS can perform beneficial angiogenic functions (11, 
42) and subsets of CD34+ cells co-expressing endothelial antigens have endothelial 
progenitor cell (EPC) characteristics. However, controversy over precise definitions 
of EPCs and other angiogenic cells has slowed progress in the field (53, 92), making 
it difficult to reach consensus on which cells should be targeted for investigation of 
exercise-induced effects on cell-based endothelial repair mechanisms. It is generally 
agreed upon that CD34+ progenitor cells, whether through actions of particular 
endothelial-directed subsets or by acting as a pool of generic progenitors, perform 
proangiogenic actions that contribute to the maintenance of vascular endothelial 
integrity (55, 56). CD34+ cell numbers predict cardiovascular (CV) disease risk and 
are functionally susceptible to adverse effects resulting from lifestyle related 
metabolic and CV disease in vivo environment (52, 55, 56). In addition, CD34+ 
PBMCs have recently received a great deal of attention in the literature for cell 
therapy applications, with a recent study finding a reduction in myocardial infarct size 
following coronary infusion of CD34+ bone marrow cells (171).  However, no studies 
have investigated the effects of acute or chronic exercise on functional aspects of 
CD34+ cells. 
There is growing evidence that acute and chronic endurance exercise increase the 
functional capacity of circulating angiogenic cells (93, 109, 198, 228-230), but the 
mechanisms underlying the functional adaptations to exercise training are not clear. 
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The balance between nitric oxide (NO) and superoxide ( O2     ·-
 
) production is a critical 
mechanistic aspect of the angiogenic functions of cultured progenitor cells (61, 216), 
and there is a link between CV/metabolic disease and reduced NO/increased O2     ·-
 
 
production in EPCs (199, 215). There have been some recent investigations into 
whether exercise training favorably alters the balance between NO and O2     ·-
 
 levels in 
circulating angiogenic cells. For example, we reported that increased activity of the 
pro-oxidant enzyme NADPH oxidase is a mechanistic mediator of lower intracellular 
NO levels in cultured EPCs of sedentary compared to trained men (109). 
Additionally, a recent study found that exercise training in metabolic syndrome 
patients increases NO production and reduced O2     ·-
 
 production in cultured EPCs, in 
conjunction with increased endothelial repair capacity in vivo (199). However, the 
effects of exercise training on intracellular NO and O2     ·-
 
 need to be examined in 
CD34+ cells, given their angiogenic properties discussed above. Furthermore, no 
exercise-based EPC studies have tested the assumption that the phenotype of cells 
generated after several days in culture under powerful angiogenic conditions 
accurately reflects the in vivo phenotype, and thus there is a need to examine cells in 
their freshly-isolated state.  
Another issue that has not received adequate attention is whether acute exercise 
alters oxidant status of circulating angiogenic cell types. Acute exercise increases NO 
production (109) and the migratory capacity (228) of cultured EPCs. However, no 
studies have directly assessed the effects of acute exercise on O2     ·-
 
 production in any 
angiogenic cell type. Given the known role for acute exercise-induced oxidative stress 
as a stimulus for beneficial adaptive responses in the form of increased NO 
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bioavailability and up-regulation of antioxidant defense systems in muscle (110) and 
the vasculature (69), there is a need to investigate the effects of acute exercise on 
circulating cells with angiogenic function. 
Therefore, we tested the hypothesis that acute and chronic endurance exercise 
would favorably influence the balance between NO and O2     ·-
 
 in freshly-isolated 
CD34+ PBMCs, and elevated NADPH oxidase activity in cells of the sedentary group 
would be a causal mechanism underlying these effects. We also hypothesized that the 
expression of genes involved in the regulation of intracellular NO and O2     ·-
 
 levels 
would be consistent with greater antioxidant capacity and angiogenic function in the 
trained state. Finally, although there are angiogenic monocytic and T-cell 
subpopulations within the CD34- PBMC fraction (15, 34, 79, 120, 122, 240), no 
studies have examined the effects of acute or chronic endurance exercise on their 
functional properties. Thus, we also explored the effects of acute and chronic exercise 
on NO, O2     ·-
 
, and gene expression in CD34- PBMCs. 
METHODS 
Screening. All potential participants completed medical and physical activity 
history questionnaires that we have used previously (109). All participants were 
nonsmoking men age 18-35 with no history and currently free of CV disease and 
diabetes. Subjects were normotensive and were not on cholesterol, antihypertensive, 
or antihyperglycemic agents. Endurance-trained individuals (n = 10) performed at 
least 4 hr/wk of endurance exercise, and sedentary individuals (n = 10) reported 
engaging in exercise for <20 min/d on <2 days/wk. Groups were matched for age and 
body mass index. The study was approved by the University of Maryland College 
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Park Institutional Review Board and all participants provided written informed 
consent.  
Maximal graded exercise test and body composition. All testing occurred in the 
morning after an overnight fast. Participants refrained from alcohol, vitamins, and 
caffeine for 12 hrs and antihistamines or NSAIDs for 24 hrs prior to testing. Body 
composition was estimated using the 7-site skinfold procedure (107). Maximal 
oxygen uptake (V
 .
O2max) was assessed using a constant-speed treadmill protocol with 
2-3% increases in incline every 2 min until exhaustion. Subjects ran at a treadmill 
speed chosen by the investigator based on subject experience, typical run speed, and 
heart rate such that V
 .
O2max was achieved in 6-12 min. Pulmonary ventilation and 
expired gas concentrations were analyzed in real time using an automated 
computerized indirect calorimetry system (Oxycon Pro, Viasys). V
 .
O2 was considered 
maximum if a plateau was achieved (increase in V
 .
O2 of < 250 ml/min with increased 
work). In the absence of a clear plateau, tests were verified to meet at least two of the 
following secondary criteria of maximal effort: a respiratory exchange ratio >1.10, a 
rating of perceived exertion >18, and a peak heart rate within 10 beats/min of the age-
predicted maximum. Heart rate was measured during the test using heart rate 
monitors (Polar).  
Submaximal exercise test. Subjects reported to the laboratory 2-7 days following 
their V
 .
O2max test. The endurance-trained subjects performed one of their usual 
exercise training sessions 16-24 hrs before this test. Seated blood pressure was 
measured and blood samples were obtained before and after exercise for assessment 
of conventional CV risk factors (baseline sample only), hematocrit, hemoglobin, and 
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isolation of circulating CD34+ and CD34- cells. The exercise consisted of 30 min of 
treadmill running at 75% of the subject's V
 .
O2max. The treadmill speed was the same 
as that used for the maximal test and % incline was adjusted to elicit the appropriate 
intensity according to the ACSM equation for V
 .
O2 during treadmill running (6). 
Intensity was verified using the heart rate reserve method.  
Isolation of CD34+ cells. PBMCs were isolated from 30 ml EDTA-anticoagulated 
blood samples using density gradient centrifugation. CD34+ enriched PBMCs were 
obtained using immunomagnetic selection according to the manufacturer’s 
instructions (Stemcell Technologies). Briefly, the final PBMC pool was resuspended 
in PBS + 2% FBS at a density of 2 × 108 cells/ml. The CD34+ selection antibody 
cocktail was added (100 µl/ml) to the PBMC suspension and incubated at room 
temperature for 15 min. Magnetic nanoparticles were then added (100 µl/ml) and 
incubated for 10 min, and PBS + 2% FBS was added to bring suspensions to a final 
volume of 2.5 ml. Cells were then incubated in the selection magnet for 5 min. CD34+ 
cells remain attached to the side of the tube, and CD34- cells were poured off in the 
supernatant. The magnetic incubation step was repeated, and CD34+ and CD34- cell 
fractions were counted by hemocytometer. Flow cytometry analysis of the 
immunomagnetically-purified CD34+ and CD34- cell fractions indicated 59% purity 
in the positively-selected fraction. Importantly, we found no detectable CD34+ cells 
in the CD34-depleted fraction. These values are comparable to or better than 
previously-published purity values for immunomagnetically-selected CD34+ cells 
from unmobilized adult peripheral blood. For example, the purity of CD34+ cells 
reported by Asahara et al. (13) was only 16%, and Schatteman et al. have reported 
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CD34+ cell purity values ranging from 20-50% (79, 183, 186). Finally, the percent 
yield of immunomagnetically purified CD34+ was not affected by acute exercise 
(~1% of total PBMCs both before and after exercise).  In addition, PCR confirmed 
high expression of CD34 mRNA in CD34+ enriched cells, with only faint expression 
detected in CD34- cells.  
Detection of intracellular free radicals and inhibition of NADPH oxidase 
activity. NO measurements were performed in duplicate as we have described 
previously (109), with modifications to examine freshly-isolated cells in a 96-well 
format. Briefly, 1.5 × 105 cells stained with 10 µM DAF-FM diacetate for 
determination of NO levels and 10 µM dihydroethidium (DHE) for determination of 
O2     ·-
 
 levels (Molecular Probes). Cells were also incubated with or without 1 mM 
apocynin (a pharmacologic NADPH oxidase inhibitor) to determine the mechanistic 
role of NADPH oxidase underlying the effects of acute exercise or differences 
between trained and sedentary groups. Cells were incubated with DAF-FM, DHE and 
drug or vehicle treatments in a final volume of 150 µl serum-free PBS for 60 min at 
37°C. Excess DAF-FM and DHE were removed by centrifugation at 500g for 5 min 
and cells were resuspended in 150 µl PBS. NO fluorescence was quantified using a 
fluorescent plate reader (Wallac Victor2 1400, Perkin Elmer) using excitation and 
emission filters of 488 and 535 nm, respectively. O2     ·-
 
 fluorescence was measured 
using excitation and emission filters of 543 and 620 nm, respectively. NO and O2     ·-
 
 
fluorescence values were normalized to cell number and are expressed relative to the 
mean for the endurance-trained group’s baseline CD34+ cells. Intra-assay coefficients 
of variation for NO and O2     ·-
 
 were 3.6% and 2.6%, respectively. Because each assay 
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was performed on different days for each subject, inter-assay coefficients of variation 
were determined on blank samples (PBS only) to document the day-to-day variability 
in arbitrary/background fluorescence. The inter-assay coefficients of variation were 
5.0% and 2.7% for NO and O2     ·-
 
 assays, respectively, indicating good day-to-day 
reliability of the assays. For validation of the fluorescent probes, unfractionated 
PBMCs and in CD34+-enriched cells were treated with a NOS inhibitor (L-NAME, 
300 uM) and a SOD mimetic (Tempol), which reduced the DAF and DHE 
fluorescence signals, respectively, to ~10-20% of basal levels (n = 3 in pilot 
experiments). Conversely, for positive controls, treatment of cells with NO and O2     ·-
 
 
donor 3-morpholino-sydnomine dose-dependently increased the DAF and DHE 
signals in by ~1200-1800 fold compared to basal levels.   
Semiquantitative reverse-transcriptase PCR. mRNA levels of endothelial nitric 
oxide synthase (eNOS), NADPH oxidase subunits gp91phox and p47phox, superoxide 
dismutases (SOD; SOD1 and SOD2) and glutathione peroxidase-1 (GPX-1) were 
measured exactly as described previously (109). Additionally, cells were examined 
for expression of CD34 (forward primer: TGAAAAAGCTGGGGATCCTAGA, 
reverse primer: TCCCAGGTCCTGAGCTATAGCC), vascular endothelial growth 
factor (VEGF) (forward primer: AAGGAGGAGGGCAGAATCAT, reverse primer: 
ATCTGCATGGTGATGTTGGA), and inducible NOS (iNOS; forward primer: 
GGCCGCAGAGAACTCAGCCTCA, reverse primer: 
CTCAAAACAGCCGCTTCCCCAGAA). PCR products were electrophoresed on 
1.5% agarose gels and visualized under UV light. Band intensities were quantified 
using imageJ and normalized to the signal for 18S as a reference gene. Data are 
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expressed relative to the endurance-trained group’s normalized baseline value (set at 
100%).  
Statistics. Data were analyzed using a two-factor [group (trained or sedentary) × 
time (baseline and after exercise)] repeated measures ANOVA. Assumptions of 
normality and homoscedasticity were verified for all data. The criterion for statistical 
significance was P ≤ 0.05. Data are presented as means ± SEM.  
RESULTS 
Subject characteristics. Endurance-trained and sedentary groups were 
successfully matched for age and BMI, but differed substantially (~33%; P < 0.05) in 
terms of V
 .
O2max (Table 4.1). For one subject in the endurance-trained group, only 
baseline data were available (thus n = 9 for endurance-trained subjects after exercise).  
Intracellular NO and O2     ·-
 
 
CD34+ cells. Sedentary subjects had 26% higher baseline NO levels compared to 
endurance-trained subjects (P < 0.05, Fig 4.1A) and NO levels in the trained group 
tended to increase with acute exercise (P = 0.055; Fig 4.1A). Apocynin treatments 
had no effect on NO levels of CD34+ cells in either group (P > 0.05). Analysis of 
main effects revealed greater NO in CD34+ cells of the sedentary group with data 
collapsed across treatment conditions (P = 0.005). The sedentary group also had 
higher O2     ·-
 
 levels at baseline (P < 0.05; Fig 4.1B). O2     ·-
 
 levels increased in the 
endurance-trained group with acute exercise (P < 0.05) but did not change in the 
sedentary group (P > 0.05). Treatment with apocynin reduced O2     ·-
 
 levels in the 
sedentary group both before and after exercise relative to their baseline vehicle-
control condition (P < 0.05) such that baseline group differences were completely 
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abolished (P < 0.05). However, apocynin treatment had no effect on O2     ·-
 
 in CD34+ 
cells from the trained group.  
CD34- cells. The sedentary and endurance-trained groups had similar NO levels at 
baseline (Fig 4.2A). In the trained group, there was no effect of acute exercise on NO 
levels, although apocynin (~45%, P < 0.05) increased NO levels both at baseline and 
after acute exercise. Acute exercise tended to increase NO in the sedentary group by 
38% (P = 0.10), and this increase resulted in a significant difference between the 
groups after acute exercise (56% greater NO levels in the sedentary group; P < 0.05). 
Apocynin increased NO levels in CD34- cells from the sedentary group by 46% at 
baseline and by 41% after acute exercise compared to their baseline vehicle-control 
condition (both P < 0.05). At baseline, NO levels increased with apocynin treatment 
to a greater extent in CD34- cells of the sedentary group compared to the trained 
group (group difference of 40%, P < 0.05). The difference between the groups was 
not statistically significant in apocynin-treated CD34- cells after acute exercise. There 
were no significant effects of training status, acute exercise, or apocynin on O2     ·-
 
 
levels in CD34- cells (Fig 4.2B).  
Gene expression 
CD34+ cells. Endurance-trained subjects had ~2-fold greater eNOS mRNA levels 
in CD34+ cells compared to sedentary subjects at baseline (P < 0.05), and a similar 
trend was observed after acute exercise (P = 0.08; Fig 4.3A). iNOS mRNA levels in 
the sedentary group were ~2-fold greater than those of the trained group at baseline 
and after acute exercise (both P < 0.05; Fig 4.3B). VEGF mRNA levels were (~20%) 
higher in the trained group at baseline (P < 0.05) but the difference between the two 
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groups was not significant after acute exercise (Fig 4.3C). SOD1 mRNA levels were 
~25% and 40% higher in cells of the trained group before and after acute exercise, 
respectively (P < 0.05), with the sedentary group having a significant acute exercise-
induced decrease in SOD1 mRNA (Fig 4.3D). There were no significant effects of 
acute exercise or training status on SOD2 or GPX1 mRNA levels (Fig 4.3E and F). 
p47phox mRNA levels were higher in the trained subjects compared to the sedentary 
group at baseline (~40%, P < 0.05) and after acute exercise (~50%, P < 0.05; Fig 
4.3G). Both groups had significant acute exercise-induced decreases in p47phox 
mRNA levels (P < 0.05). gp91phox mRNA levels in CD34+ cells were similar between 
groups but differed after exercise by ~40% (P < 0.05; Fig 4.3H). Both groups had 
significant exercise-induced reductions in gp91phox mRNA levels (P < 0.05). 
CD34- cells. eNOS mRNA levels were ~25% lower in the sedentary group at 
baseline and increased with acute exercise in the sedentary group (P < 0.05, Fig 
4.4A). However, there were no differences in iNOS mRNA levels between groups or 
effects of acute exercise for either group (Fig 4.4B). Endurance-trained subjects had 
~25% higher baseline VEGF mRNA levels than the sedentary group at baseline (P < 
0.05, Fig 4.4C), and groups had similar VEGF mRNA levels after acute exercise. 
There were no differences between groups in SOD1, SOD2, or GPX1 (Fig 4.4D-F) at 
baseline, and acute exercise-induced increases were only evident in the sedentary 
group (P < 0.05 for SOD1 and SOD2, P = 0.08 for GPX1). There were no differences 





 The major findings in the CD34+ cell fraction are (i) intracellular NO and O2     ·-
 
 
levels are higher in sedentary than endurance-trained men; (ii) the effect of training 
status on O2     ·-
 
, but not NO levels, is NADPH oxidase-dependent; and (iii) mRNA 
levels of a number of angiogenic and antioxidant genes are lower in sedentary than 
trained men. Together, these findings point to increased nitro-oxidative stress in the 
sedentary state. Importantly, these data were obtained from a carefully selected and 
screened study sample of healthy, lean, young men with low risk for CV disease. 
Thus, the molecular changes in CD34+ cells from sedentary subjects apparently occur 
associated with impaired angiogenic potential in circulating CD34+ cells may occur 
very early in the disease-related process associated with a sedentary lifestyle.  
 Our finding of higher intracellular NO in CD34+ cells of the sedentary group was 
contrary to our original hypothesis. Data from human and animal studies indicate that 
maintaining optimal levels of intracellular NO in vascular endothelial cells is a key 
mechanism by which exercise improves CV health (78, 126). Additionally, we and 
others have previously shown that cultured EPCs seem to exhibit similar NO-related 
biology compared to fully differentiated endothelial cells. For example, cultured 
angiogenic cells upregulate endothelial and angiogenic genes in response to shear 
stress (254). EPCs of CAD patients had undetectable eNOS and impaired migratory 
capacity that was reversed upon treatment with a NO donor (88). We previously 
reported that cultured EPC colonies from endurance-trained individuals had higher 
NO levels compared to sedentary individuals (109). Together, these previous data 
provided a strong rationale for our original hypothesis that trained men would have 
higher NO in circulating CD34+ cells.  
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These previous investigations were based on the premise that eNOS is the primary 
source of NO in endothelial cells, and, by extension, in angiogenic cells that take on 
an endothelial phenotype in culture. However, the iNOS isoform also produces NO in 
large quantities in hematopoietic cells (213). The expression and activity of iNOS 
relative to eNOS can determine whether NO performs beneficial physiological 
functions (e.g. vasodilation in ECs, progenitor/angiogenic cell migration and homing) 
or harmful pathophysiological functions (e.g. inflammation, nitro-oxidative damage 
to cell components, and apoptosis) (157, 191, 222). These adverse consequences of 
high NO are amplified in the presence of excess O2     ·-
 
, as the interaction of these two 
radicals results in the rapid and spontaneous formation of peroxynitrite (213). 
Peroxynitrite increases iNOS expression (32) and promotes uncoupling of the eNOS 
reaction (61). Thus, the present findings of greater iNOS gene expression, lower 
eNOS gene expression, greater NO levels, and greater NADPH oxidase-derived O2     ·-
 
 
production in the sedentary group are suggestive of a state of increased nitro-
oxidative stress in CD34+ cells of sedentary individuals. However, our cross-sectional 
study design allows us to conclude that we have identified an association, but not 
necessarily a cause-effect relationship, between a sedentary lifestyle and increased 
nitro-oxidative stress.  
 It is also possible that our present finding of higher levels of NO in cells from the 
sedentary group was in contrast with our previous finding of higher NO levels in 
cultured EPCs from trained compared to sedentary men (109) because of the 
difference between cultured and freshly-isolated cell characteristics. Our use of 
freshly-isolated cells in the present study is a very different approach compared to 
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using cultured PBMC-derived EPCs grown in a powerful endothelial growth 
environment (i.e. exposure of high concentrations to known endothelial growth 
factors for 5 days), as in our previous study. It is reasonable to suggest that cells from 
exercise-trained subjects may be primed for endothelial-directed differentiation under 
angiogenic growth conditions, owing to their higher expression of eNOS (in ref. 20, 
and replicated in both cell fractions of the present study) and VEGF gene expression.  
 It was surprising that NO and O2     ·-
 
 levels increased with exercise in CD34+ cells 
from the trained group but not the sedentary group, which also contrasted with our 
previous data (109). An important aspect of our study with respect to the acute 
exercise data is that we obtained samples at only one time point after exercise. A time 
course experiment is warranted to determine whether NO and/or O2     ·-
 
 in freshly-
isolated CD34+ cells are unaffected by acute exercise in sedentary individuals, or 
whether training status determines the temporal nature of the response. 
 Treatment of CD34+ cells with apocynin reduced intracellular O2     ·-
 
 in the 
sedentary group and a normalization of the baseline O2     ·-
 
 difference between groups, 
suggesting that the training-related difference in O2     ·-
 
 observed at baseline was a 
result of increased NADPH oxidase enzymatic activity in the sedentary group. 
Excessive NADPH oxidase-derived O2     ·-
 
 has been implicated in oxidative stress-
related dysfunction of progenitor cell angiogenic activities (61). Our data provide the 
first evidence that NADPH oxidase activity is elevated in freshly-isolated CD34+ 
cells of sedentary individuals, and it is important to emphasize that because we 
matched groups for age and BMI, we are confident that we have isolated the effect of 
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chronic exercise training to the extent possible given the cross-sectional study design. 
Nevertheless, these findings will require confirmation in a future prospective study.   
 The major findings in the CD34- cell fraction are (i) training status modifies the 
regulatory effect of NADPH oxidase enzyme activity on intracellular NO 
concentrations, as indicated by the effect of apocynin on NO being different between 
the sedentary and trained groups; (ii) regular endurance exercise is associated with 
enhanced angiogenic gene expression (i.e., VEGF and eNOS); and (iii) acute exercise 
increases antioxidant gene expression in CD34- cells of sedentary individuals.    
The greater response of NO levels to apocynin treatment in the sedentary group than 
in the trained group is possibly indicative of greater basal NADPH oxidase enzymatic 
activity in the sedentary group. This finding is in line with our previous observations 
in putative EPC colonies, most of which are CD34- (109). Thus, further research is 
required to link the role of NADPH oxidase enzymatic activity and its regulatory 
effects on NO levels with angiogenic actions of particular CD34- cellular subsets. In 
addition, our data suggest that the angiogenic properties of CD34- cells may be 
enhanced by acute and chronic endurance exercise, as indicated by the higher levels 
of basal VEGF and eNOS mRNA in trained compared to sedentary subjects, and also 
by the acute exercise-induced increased in antioxidant genes in CD34- cells of 
sedentary subjects. However, the CD34- cells as a whole should probably not be 
thought of as angiogenic per se, as these cells are mostly white blood cells (T-cells, 
monocytes, etc) with primarily immune function, and it would be interesting to know 
which cell populations within the CD34- fraction are driving the present results. A 
reasonable hypothesis for future research is that the functions of angiogenic CD34- 
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monocyte and T-cell fractions (15, 34, 79, 120, 122) may benefit from acute (based 
on our finding of increased antioxidant gene expression) and chronic (based on our 
finding of higher eNOS and VEGF gene expression) endurance exercise. 
  Limitations. It would have been advantageous to have selected additional 
subpopulations within the CD34+ fraction, e.g. CD34+/VEGFR2+ or CD34+/CD45- 
EPCs, however cell yields in pilot studies were too low to perform NO or O2     ·-
 
 assays. 
Thus, we chose to examine only two subfractions based on the presence or absence of 
the CD34 antigen, which yielded an appropriate number of cells to work with and 
seemed reasonable given their accepted role as proangiogenic cells under certain 
conditions. We did not measure all aspects of angiogenic function (e.g., in vitro 
capillary formation, migration, and assessments of target genes at the protein level), 
and clearly data generated from such assays would have aided the interpretation of 
the unexpected finding of higher NO levels in CD34+ cells of the sedentary group.  
  Conclusions. The present study provides the first evidence that physical 
inactivity is associated with increased nitro-oxidative stress in CD34+ cells, and it 
appears that the notion that higher levels of NO are necessarily associated with 
beneficial cellular outcomes will require further investigation. In particular, the 
relative contribution of eNOS vs. iNOS activities to CD34+ cell-mediated vascular 
endothelial maintenance needs to be examined. As we have investigated these 
outcomes in healthy young men at low risk for CV disease, we have isolated the 
effects of exercise training independent of other confounding factors. Thus, we 
anticipate that the information provided by our study will be particularly useful for 
the development of therapeutic applications of CD34+ cells in regenerative medicine. 
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The efficacy of cell therapy trials may be improved if exercise training as a strategy 
to reduce nitro-oxidative stress were employed in conjunction with cell infusions. 
However, further investigation is required to confirm the nitro-oxidative stress at the 
functional level (e.g. nitration of proteins) in CD34+ cells. Overall, our data provide 
strong a rationale for further research to clarify the mechanisms of exercise-induced 
improvements in the vascular repair capacity of circulating CD34+ PBMCs.  
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Table 4.1. Subject characteristics.   
 Endurance-Trained Sedentary  
 (n = 10) (n = 10) 
Age (y) 25 ± 1 25 ± 1 
BMI (kg·m-2) 22.1 ± 1 23.9 ± 1 
Body fat (%) 7.1 ± 0.4 14.9 ± 1.3* 
Glucose (mg·dl-1) 78 ± 2  79 ± 4 
Cholesterol (mg·dl-1) 165 ± 6  171 ± 12 
HDL-C (mg·dl-1) 65 ± 4 54 ± 4* 
LDL-C (mg·dl-1) 88 ± 4 99 ± 13 
TC/HDL 2.6 ± 0.1 3.4 ± 0.4 
LDL/HDL 1.4 ± 0.1 2.0 ± 0.4* 
VLDL-C (mg·dl-1) 11 ± 0.9 19 ± 2* 
Triglycerides (mg·dl-1) 57 ± 5 95 ± 9* 
SBP (mm Hg) 121 ± 3 119 ± 2 
DBP (mm Hg) 74 ± 2 76 ± 4 
MAP (mm Hg) 90 ± 2 91 ± 2 
V
 .
O2max   
   l·min-1 4.82 ± 0.13 3.68 ± 0.14* 
   ml·kg-1·min-1 70.3 ± 0.9 46.9 ± 1.5* 
   ml·kg FFM-1·min-1 75.6 ± 1.1 55.1 ± 1.5* 
*Statistically significant difference between groups (P < 0.05). Abbreviations: BMI, 
body mass index; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density 
lipoprotein cholesterol; VLDL-C, very low-density lipoprotein-cholesterol; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; 
V
 .






























































































Figure 4.1. Nitric oxide (NO; panel A) and superoxide (panel B) fluorescence in 
CD34+ cells of endurance-trained and sedentary men before and after acute exercise. 
*Statistically significant difference between groups within the given experimental 
condition (P < 0.05); †Statistically significant within-group change relative to 

























































































Figure 4.1. Nitric oxide (NO; panel A) and superoxide (panel B) fluorescence in 
CD34- cells of endurance-trained and sedentary men before and after acute exercise. 
*Statistically significant difference between groups (P < 0.05) within the given 
experimental condition; †Statistically significant within-group change relative to 
baseline control sample (P < 0.05).  
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Figure 4.3. mRNA levels of eNOS (A), iNOS (B), VEGF (C), SOD1 (D), SOD2 (E), 
GPX-1 (F), p47phox (G), and gp91phox (H) in CD34+ cells of endurance-trained and 
sedentary men before and after acute exercise. (I) RT-PCR agarose gel 
electrophoresis products shown are representative of data presented in panels A-H; 
separate images from the same gel are shown for each target gene. Abbreviations: ET 
= endurance-trained group; S = sedentary group.  *Statistically significant difference 
between groups within the given experimental condition (P < 0.05); †Statistically 




Figure 4.4. mRNA levels of eNOS (A), iNOS (B), VEGF (C), SOD1 (D), SOD2 (E), 
GPX-1 (F), p47phox (G), and gp91phox (H) in CD34- cells of endurance-trained and 
sedentary men before and after acute exercise. (I) RT-PCR agarose gel 
electrophoresis products shown are representative of data presented in panels A-H; 
separate images from the same gel are shown for each target gene. Abbreviations: ET 
= endurance-trained group; S = sedentary group.  *Statistically significant difference 
between groups within the given experimental condition (P < 0.05); †Statistically 
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OBJECTIVE: We hypothesized that prior exercise would prevent postprandial 
lipemia (PPL)-induced increases in intracellular reactive oxygen species (ROS) in 
three distinct circulating angiogenic cell (CAC) subpopulations.  
METHODS and RESULTS: CD34+, CD31+/CD14-/CD34-, and 
CD31+/CD14+/CD34- CACs were isolated from blood samples obtained from ten 
healthy men before and 4 hr after ingesting a high fat meal with or without ~50 min 
of prior endurance exercise. Significant PPL-induced increases in ROS production in 
both sets of CD31+ cells were abolished by prior exercise. Experimental ex vivo 
inhibition of NADPH oxidase activity and mitochondrial ROS production indicated 
that mitochondria were the primary source of PPL-induced oxidative stress. The 
attenuated increases in ROS with prior exercise were associated with increased 
antioxidant gene expression in CD31+/CD14-/CD34- cells and reduced intracellular 
lipid uptake in CD31+/CD14+/CD34- cells. These findings were associated with 
systemic cardiovascular benefits of exercise, as serum TG, OxLDL, and plasma EMP 
concentrations were lower in the exercise trial than the sedentary trial. 
CONCLUSIONS: Prior exercise completely prevents PPL-induced increases in ROS 
in CD31+/CD14-/CD34- and CD31+/CD14+/CD34- cells. The mechanisms underlying 





Ingestion of a high-fat meal increases serum triglyceride concentrations (TG), 
induces systemic oxidative stress, and impairs vascular endothelial function (220, 
237). As the majority of individuals in Western society are in a postprandial state 
most of the time (196), routine exposure to postprandial lipemia (PPL) and the 
associated endothelial dysfunction may affect the development of cardiovascular 
(CV) disease (7). PPL-induced vascular endothelial dysfunction is thought to be 
mediated by oxidative stress resulting from an increased lipid load within the cell, in 
turn leading to increased oxidative metabolism and excess production of reactive 
oxygen species (ROS) (16, 239). The primary consequences of increased ROS 
production are nitric oxide (NO) scavenging and uncoupling of the endothelial NO 
synthase (eNOS) enzyme (159), ultimately resulting in reduced NO bioavailability, 
impaired NO-dependent vasodilatory function, and, with chronic exposure, a pro-
atherogenic cellular environment within the vessel wall (239).  
Prior exercise effectively reduces PPL (164, 239) and the accompanying vascular 
endothelial dysfunction (160, 221). The mechanisms underlying the protective effects 
of exercise involve up-regulation of systemic (221) and intracellular (16, 23, 239) 
antioxidant defenses that enable the preservation of NO bioavailability and vascular 
function in the face of a high-fat challenge. However, it is unknown whether these 
mechanisms are uniform throughout all CV cells and tissues. 
Circulating angiogenic cells (CACs) are now understood to be important for the 
maintenance of a healthy endothelium (250). CAC number is associated with CV 




56, 137, 212, 251). However, there are few published data on the functional responses 
of CACs to lifestyle factors. The CAC populations that have received the most 
attention are bone marrow-derived CD34+ progenitor cells that co-express endothelial 
markers (12, 13). However, although cells expressing the endothelial antigen CD31 
(34, 114, 115) and/or the monocyte antigen CD14 (15, 59, 79, 141, 178, 184) 
represent important CAC subpopulations, the effects of exercise and other lifestyle 
factors on functional aspects of these cell populations have not been studied. Finally, 
several studies have shown that PPL causes inflammation and ROS production in 
leukocytes (5, 71, 101, 235), but whether these effects are uniform among leukocyte 
subsets (including CACs) or could be ameliorated by exercise is not known.  
In the present study, we tested the effect of a high fat meal with or without a bout 
of prior endurance exercise on ROS and NO production in CD34+, CD31+/CD14-
/CD34-, and CD31+/CD14+/CD34- CACs. We also attempted to gain mechanistic 
insight into the molecular source of PPL-induced ROS using pharmacological 
inhibition of NADPH oxidase- and mitochondria oxidative activity. We hypothesized 
that PPL would reduce intracellular NO levels and increase the production of ROS by 
NADPH oxidase and/or mitochondria, and that these effects would be attenuated by a 
single bout of exercise performed on the prior day. In addition, we assessed 
concentrations of serum TG, serum oxidized LDL-cholesterol (OxLDL), and plasma 
endothelial microparticles (EMPs) to determine if exercise reduces systemic PPL-






Overview of Experimental Procedures 
Following a screening visit to obtain informed consent and assess maximal 
oxygen uptake (V
 .
O2max) and body composition [inclusion criteria: male, age 18-35 
yr, normotensive, normolipidemic, normoglycemic, not taking any medications, and 
physically active (at least 4 hr/wk participation in endurance exercise)], subjects were 
subjected to PPL tests under two separate experimental conditions: control, in which 
no prior exercise was performed, and an exercise trial, in which subjects performed 
stationary cycling at 70% V
 .
O2max until reaching an energy expenditure of 2.5 MJ 
(~50 min). Subjects remained sedentary for the entire 24 hr period preceding the PPL 
test. The exercise trial was completed ~15 hr prior to the PPL test. The order of 
treatments was randomized and balanced across the study subjects (n = 10), and 
treatments were scheduled 1 week apart. Subjects consumed a standardized meal the 
evening before the PPL test. The PPL test meal consisted of heavy whipping cream, 
chocolate syrup, sugar, and powdered milk, and provided ~1300 kcal (84% from fat). 
Additional details of the study protocol, including the exercise protocol and test meal 
macronutrient composition for each subject, are provided in the Supplemental 
Materials (Supplemental Tables 5.I and 5.II).  The University of Maryland College 
Park Institutional Review Board approved all study procedures and subjects provided 
written informed consent.  
Immunomagnetic Cell Separation 
Peripheral blood mononuclear cell (PBMCs) were isolated by density gradient 
centrifugation (Ficoll; GE Healthcare), and separated into CD34+, CD31+/CD14-




separation procedure (EasySep®, Stemcell Technologies) according to the 
manufacturer’s instructions (additional details are provided in Supplemental 
Materials).  
Experimental Inhibition of NADPH oxidase and Mitochondrial ROS Production 
NADPH oxidase was inhibited using apocynin (Sigma), and mitochondria 
respiratory complex I was inhibited by rotenone (Sigma; additional details are 
provided in the Supplemental Materials). 
Measurement of Intracellular NO and ROS, Intracellular Stored Neutral Lipid 
Assay, RNA Isolation and Assessment of Gene Expression, Serum Triglyceride 
and Oxidized LDL-cholesterol, Endothelial Microparticles 
These protocols are described in the Supplemental Materials.  
Statistics 
Assumptions of homoscedasticity and normality were verified for all outcome 
measures. Data were analyzed using two-factor (condition × time) or three-factor 
(condition × time × drug) repeated measures ANOVA, where appropriate. Analyses 
of simple effects were used to determine differences between control and exercise 
treatments at specific time points. Total TG areas under the lipemia curves (TG AUC) 
were calculated using the trapezoid rule (140) and compared between control and 







Anthropometric and clinical characteristics of the study subjects are presented in 
Table 5.1.   
Intracellular ROS and NO Levels 
Reactive oxygen species. In CD31+/CD14-/CD34- cells, there was a ~30% 
increase in ROS with PPL in the control condition (P < 0.05), and this effect of PPL 
was completely absent in the prior exercise trial (Fig 5.1A). Apocynin increased ROS 
levels at both 0- and 4-hr time points in both trials (P < 0.05), but the magnitudes of 
these increases were significantly greater in the control trial compared to the trial with 
prior exercise (P < 0.05). The apocynin-induced increase in ROS levels in these and 
the two other cell types (presented below) was a surprising finding, given the 
hypothesis of the study that NADPH oxidase-inhibition would experimentally 
demonstrate that the PPL-induced increase in ROS would be driven by NADPH 
oxidase. When we observed that these findings were consistent and statistically 
significant after testing the first 5 subjects of the study, we attempted to determine if 
another cellular source of pro-oxidant activity could have compensated for NADPH 
oxidase inhibition by increasing ROS production. Thus, before testing the remaining 
participants, we examined the effects of allopurinol (a xanthine oxidase inhibitor), 
rotenone (a mitochondrial complex I inhibitor), and antimycin (a mitochondrial 
complex III inhibitor) in combination with apocynin (n = 3 pilot subjects). It was 
found that the most consistent inhibitor of the apocynin-induced increase in ROS was 
rotenone, i.e. ~60-100% of the increase could be eliminated by rotenone compared to 
~20% by allopurinol and <10% by antimycin (data not shown). Therefore, rotenone 




increases in ROS in CD31+/CD14-/CD34- cells were completely reversed by rotenone 
in both the control and prior exercise trials (P < 0.05). ROS levels were lower in the 
prior exercise trial compared to the control trial under all experimental conditions (P 
< 0.05).  
In CD31+/CD14+/CD34- cells, PPL increased ROS by ~25% in the control trial (P 
< 0.05), and this increase was absent in the trial with prior exercise (Fig 5.1B). 
Apocynin substantially increased ROS levels at both time points during both trials (P 
< 0.05), and again this was completely reversed by rotenone treatment (P < 0.05). The 
magnitude of the increase in ROS levels with apocynin treatments and the degree of 
reduction by rotenone treatments were similar between control and exercise trials. 
In CD34+ cells, PPL induced a small (~10%), but statistically significant increase 
in ROS in the trial with prior exercise (P < 0.05), but no change was observed in the 
control trial (Fig 5.1C). NADPH oxidase inhibition with apocynin induced ~2-2.5 
fold increases in ROS levels at 0 hr and 4 hr in both the control and prior exercise 
trials (P < 0.05), which was completely attenuated by co-incubation with rotenone (P 
< 0.05).  
Nitric Oxide. There were no effects of PPL or apocynin on NO levels in either the 
prior exercise or control trial in CD34+/CD14-/CD34- cells (Fig 5.2A). In 
CD34+/CD14+/CD34- cells, PPL increased NO levels both with and without apocynin 
treatments by ~10-15% in the control trial (P < 0.05), but there were no effects of 
PPL or apocynin in the prior exercise trial (Fig 5.2B). PPL had no effect on NO in 




trial with prior exercise (P < 0.05). This 10% reduction in NO was reversed upon 
treatment with apocynin (Fig 5.2C). 
Intracellular Neutral Lipid Storage 
Within the CD34+ cells, PPL caused a significant increase in stored neutral lipids 
during the prior exercise trial (P < 0.05), but there was no change during the control 
trial (Fig 5.3). There were no significant PPL-induced changes in stored neutral lipids 
in CD31+/CD14-/CD34- cells in either trial. In CD31+/CD14+/CD34- cells, 
intracellular lipids increased significantly in the control trial (P < 0.05), but there was 
no effect of PPL in the prior exercise trial. There were no differences in basal (0 hr) 
stored neutral lipid levels between the control and prior exercise trials (data not 
shown). 
Circulating TG, OxLDL, and EMP Concentrations 
Fasting (i.e., 0-hr) serum concentrations of TG and OxLDL were not different 
between trials (P > 0.05; Fig 5.4). Serum TG concentrations increased significantly 
throughout the sampling period in both the control and prior exercise trials (P < 0.05), 
but the concentrations were lower (P < 0.05) at 1 and 3 hr, and tended to be lower at 4 
hr (P = 0.06), during the prior exercise trial compared to the control trial (Fig 5.4A). 
TG AUC was significantly lower in the prior exercise trial compared to the control 
trial (Fig 5.4B, P < 0.05). There was a 28% increase in serum oxLDL concentration in 
the control trial (P < 0.05), and there was no change in oxLDL concentration in 
response to the high-fat meal with exercise performed on the prior day (Fig 5.4C and 
D). Plasma EMP markers of endothelial activation (Fig 5.5A) and endothelial 




trial (55% and 30%, respectively; both P < 0.05), but were unaffected by the high-fat 
meal in either trial.  
Gene Expression 
Overall, the pattern of gene expression varied considerably among the three cell 
types in response to PPL with and without prior endurance exercise. The major 
finding was that prior exercise increased expression of the antioxidant genes 
superoxide dismutase (SOD)-1 and SOD2 in CD31+/CD14-/CD34- cells at both 0 hr 
and 4 hr time points, while SOD1 and SOD2 gene mRNA levels were not affected by 
prior exercise in either CD31+/CD14-/CD34- or CD34+ cells. Additional data on 
mRNA levels of endothelial nitric oxide synthase (eNOS), inducible NOS (iNOS), 
vascular endothelial growth factor (VEGF), NADPH oxidase subunits gp91phox and 
p47phox, and the oxidized LDL-cholesterol receptor-1 (LOX1) are presented in 
Supplemental Figures 5.II-IV.    
DISCUSSION 
The major finding of this study is that PPL increases intracellular ROS in 
CD31+/CD14-/CD34- and CD31+/CD14+/CD34- PBMCs, and this effect is prevented 
by performing endurance exercise on the prior day. Consistent with previous data 
indicating that postprandial oxidative stress is caused by an increase in mitochondria-
derived ROS production (23, 239), our data implicate mitochondria as a possible 
source of PPL-induced increases in intracellular ROS in the CD31+ CAC 
subfractions. In addition, we observed beneficial effects of exercise on PPL-induced 
changes in intracellular storage of neutral lipids and expression of genes involved in 




cells (i.e., elevated ROS, reduced NO, and increased stored neutral lipid) in the prior 
exercise trial only. Therefore, our data suggest that the effects of exercise are not 
uniform among CAC subpopulations.  
Exercise Protects Against High-fat Meal-induced Increases in Intracellular ROS 
of CD31+/CD14-/CD34- and CD31+/CD14+/CD34- Cells  
We hypothesized that NADPH oxidase would play a role in the effects of PPL-
induced oxidative stress, as PPL has been shown to increase OxLDL (220), and 
OxLDL increases NADPH oxidase expression in cultured CACs (135). However, in 
the present study apocynin treatment induced a dramatic increase in intracellular ROS 
levels in all three CAC types. We were able to determine that mitochondria up-
regulate ROS production with acute apocynin treatments in all three cell types 
examined, as the apocynin-induced increase in ROS was completely reversed upon 
treatment with the complex I inhibitor rotenone. Further, and more importantly, the 
protective effects of exercise against PPL-induced ROS production in both CD31+ 
cell fractions appeared to be mitochondria-dependent, as indicated by the return to 0-
hr ROS levels in rotenone-treated 4-hr cells. However, we acknowledge that a 
limitation of our study is that we did not include a rotenone-only treatment condition. 
Thus, our interpretation that mitochondria might account for the PPL-induced ROS 
increase must be taken with caution, and will require confirmation in further 
experiments designed a priori to examine the role of mitochondria. It is also 
important to mention that in our preliminary experiments, apocynin at the chosen 
concentration (250 µM) decreased basal ROS production as measured by DCF 




used similar or greater concentrations of apocynin to investigate the NADPH oxidase-
driven components of cultured endothelial cell ROS production (150) and vascular 
endothelial dysfunction (46). Thus, the up-regulation of mitochondria-derived ROS 
by apocynin in our experiments appears to be a phenomenon specific to the CAC 
populations examined in the present study, and the biology of redox regulation does 
not appear to be uniform between vessel wall endothelial cells and CACs. 
Furthermore, it is interesting that the degree of the mitochondria-mediated increase in 
ROS was blunted with prior exercise in the CD31+/CD14-/CD34- fraction, indicating 
that in these cells there was an attenuation of mitochondrial ROS production in 
response to the high-fat meal, or there may have been an up-regulation of intracellular 
antioxidant defenses that resulted in enhanced scavenging of ROS. In line with the 
latter possibility, we also found increases in both SOD1 and SOD2 mRNA levels in 
CD31+/CD14-/CD34- cells with exercise (supplemental Fig 5.II). In 
CD31+/CD14+/CD34- cells, on the other hand, the PPL-induced increase in ROS was 
similarly blunted by prior exercise, and yet there were no effects of exercise on 
antioxidant gene expression (Supplemental Fig 5.III). However, in these cells prior 
exercise caused a significant reduction in the degree of neutral lipid storage with PPL, 
which would be expected to result in attenuated ROS production (239). Regardless, 
the critical finding of the present study is protection against PPL-induced oxidative 
stress in CD31+/CD14-/CD34- and CD31+/CD14+/CD34- angiogenic cells by prior 
exercise. These findings are especially important in light of recent reports that CD31+ 
cells in bone marrow and peripheral blood are an important source of CACs for the 




regenerative medicine therapy (114, 115). Our data suggest that exercise may 
enhance the ability of CD31+ CACs to cope with a physiological pro-oxidative 
challenge, and may therefore improve the efficacy of these cells for therapeutic 
treatment of CV diseases.  
Exercise and PPL Have Minimal Effects on Intracellular NO in CACs 
 Surprisingly, there were few significant effects of PPL, exercise, or their 
interaction on intracellular NO levels in the three cell types examined in the present 
study. Given the critical role for NO in a number of CAC functions, we expected that 
NO would be reduced by PPL without prior exercise and that this reduction would be 
absent, or at least blunted, in the trial with prior exercise. Thus, the reduction in NO 
in CD34+ cells during the prior exercise trial was not anticipated. However, it was 
consistent with the gene expression data indicating that eNOS expression increased 
with PPL in the control but not the prior exercise trial (Supplemental Fig 5.IV). 
Similarly, there were no changes in NO levels in CD31+/CD14-/CD34- cells, although 
in these cells mRNA levels of both NOS isoforms were significantly increased during 
the prior exercise trial compared to the sedentary trial (supplemental Fig 5.II). These 
effects at the mRNA level were not associated with changes at the functional level 
(i.e., intracellular NO). In CD31+/CD14+/CD34- cells, conversely, PPL-induced 
increases in eNOS mRNA and in intracellular NO were observed both in the control 
trial, but not in the trial with prior exercise. However, it must be emphasized that the 
changes in NO in both CD34+ and CD31+/CD14+/CD14- cells, while statistically 
significant, were relatively small (~10%), and therefore further research is needed to 




Role of Lipid Storage and Gene Expression: Evidence for CAC Subpopulation-
specific Mechanisms Underlying Effects of Exercise 
As mentioned above, we observed higher levels of in SOD1 and SOD2 mRNA 
levels in CD31+/CD14-/CD34- cells during the prior exercise trial, but differences 
between trials in these antioxidant genes in CD31+/CD14+/CD34-. Conversely, there 
were no effects on lipid storage in CD31+/CD14-/CD34- cells, whereas in 
CD31+/CD14+/CD34- cells there was a significant reduction in the degree of PPL-
induced lipid uptake with prior exercise. Furthermore, the expression profile of the 
angiogenic, pro-oxidative, and antioxidant genes we examined varied considerably in 
response to PPL and exercise among the three cell types we investigated 
(Supplemental Figures 5.II-IV). Therefore, it would appear that the mechanisms by 
which exercise and high-fat meal ingestion alter the angiogenic functions in CACs are 
not uniform among specific CAC subpopulations.   
Exercise Blunts PPL-induced Increases in Serum TG and OxLDL and Reduces 
EMPs in Spite of PPL  
Our finding of a reduction in TG AUC following ingestion of a high-fat meal with 
exercise performed on the prior day is consistent with numerous previous studies [for 
review, see Petitt and Cureton (164)]. An increase in serum OxLDL has been 
observed in response to ingestion of a high-fat meal (220), and to the best of our 
knowledge, this is the first study to report an exercise-induced protection against this 
effect. As OxLDL has been previously reported to cause dysfunction of cultured 
CACs through increased intracellular oxidative stress (135), the mechanisms 




exposure to circulating OxLDL after the high-fat meal with prior exercise. In 
addition, our data provide the first evidence that exercise can reduce circulating 
EMPs, a well-established marker of damaged vascular endothelium (94). Specifically, 
EMP populations indicating the presence of endothelial activation and endothelial 
apoptosis were lower in the exercise trial compared to the sedentary trial, even in the 
face of the high-fat challenge, which has previously been shown to increase 
circulating EMPs (60, 220). Thus, our TG,  OxLDL, and EMP data are in line with (i) 
the known effects of a high-fat meal on TGs and on systemic oxidative stress, and (ii) 
the reduction in or prevention of PPL-induced vascular dysfunction (160, 221), which 
is mediated by oxidative stress (165, 166, 239).  
CONCLUSIONS 
In summary, we have shown that the PPL-induced increases in intracellular ROS 
production in CD31+ cells are prevented by prior endurance exercise. Our 
experiments suggested mitochondria as the source of the PPL-induced increase in 
ROS, although future studies designed a priori to determine the role of mitochondria 
in PPL-induced ROS production in CACs are required for confirmation. These 
findings add to the strong and consistent evidence that the detrimental effects of PPL 
on the CV system are mediated by oxidative stress, and our direct measurements of 
the intracellular environment within human CACs indicate that these effects of PPL 
can be prevented by prior endurance exercise. Our data also provide novel insight into 
the understanding of how situations encountered in daily life, such as exercise and 
high-fat meal ingestion, might alter the endothelial repair capacity of CACs. These 




and EMP concentrations during PPL, suggesting a systemic CV benefit of exercise 
even in the face of a high-fat challenge. Finally, our findings could provide important 
information for the ongoing efforts to optimize the application of CACs for 
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Table 5.1. Subject Characteristics. 
   Mean SEM
Age (yr) 27 0.9 
BMI (kg/m2) 24.6 0.7 
Body Fat (%) 15.1 1.2 
Glucose (mg/dl) 82 2.2 
Cholesterol (mg/dl) 163 5.8 
HDL-C (mg/dl) 54 3.2 
LDL-C (mg/dl) 93 3.7 
VLDL-C (mg/dl) 16 1.7 
TG (mg/dl) 78 8.1 
SBP (mm Hg) 120 3.0 
DBP (mm Hg) 75 1.8 




  L/min 3.75 0.2 







Figure 5.1. Effects of PPL with and without prior endurance exercise (left panels) and 
apocynin and rotenone treatments (right panels) on intracellular reactive oxygen species in 
CD31+/CD14-/CD34- (A), CD31+/CD14+/CD34- (B), and CD34+ (C) CACs. Horizontal dashed 
line at 100% indicates control (vehicle) condition. *Statistically significant difference from 0-
hr control (vehicle) condition (P < 0.05). #Magnitude of change from 0-hr control (untreated) 
condition is significantly different between control and prior exercise trials (P < 0.05). 




















































































































































































































































Figure 5.2. Effects of PPL and apocynin treatment with and without prior endurance 
exercise on intracellular nitric oxide in CD31+/CD14-/CD34- (A), 
CD31+/CD14+/CD34- (B), and CD34+ (C)  circulating angiogenic cells. *Statistically 
significant difference from 0-hr control (vehicle) condition (P < 0.05). #Change from 
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Figure 5.3. PPL-induced changes in stored neutral lipid in circulating angiogenic cells 
with and without prior endurance exercise. *Statistically significant change within trial 
(i.e., the percent change is different from zero; P < 0.05). #Magnitude of change is 























































































































Figure 5.4. Effects prior exercise on PPL as measured by serum TG concentrations 
(A), TG AUC (B), and oxLDL (C). (D) PPL-induced change (%) in OxLDL in control 
and prior exercise trials. *Statistically significant difference from 0-hr time point 
within trial (P < 0.05). †Statistically significant difference between trials (P < 0.05). 



























































































































Figure 5.5. Effects of postprandial lipemia with and without prior endurance exercise 
on plasma endothelial microparticles (EMPs). (A) EMP fragments of activated 
endothelium (CD62E+ EMPs); (B) apoptotic endothelial CD31+/CD42- EMPs. *P < 































































Expanded Materials and Methods 
Screening 
Ten healthy, nonsmoking, recreationally- to highly-active (endurance exercise 
≥4hr/week) men aged 18-35 yrs with no history of CV or metabolic disease were 
recruited for this study. Potential subjects were initially screened by telephone or 
email, and reported to the laboratory following an overnight fast for a screening visit 
to verify eligibility. Exclusion criteria were as follows: systolic blood pressure ≥130 
mm Hg, diastolic blood pressure ≥90 mm Hg, serum total cholesterol level ≥200 
mg/dl; low-density lipoprotein-cholesterol level of ≥130 mg/dl; high-density 
lipoprotein-cholesterol of ≤ 35; fasting glucose ≥100 mg/dl). The University of 
Maryland College Park Institutional Review Board approved all study procedures and 
subjects provided written informed consent. 
A blood sample was obtained for assessment of fasting serum triglycerides (TG), 
lipoprotein lipids, and glucose (Quest Diagnostics, Baltimore, MD). Height, weight, 
and body mass index were measured, and body composition was assessed using the 7-
site skinfold procedure (107). Maximal oxygen uptake (V
 .
O2max) was determined 
using a stationary cycling test to exhaustion (Life Cycle). Subjects began cycling at 
200W, and the work rate increased by 25W every 2 min until the subject was unable 
to maintain a cycling cadence of ≥50 revolutions/min. V
 .
O2 was measured 
continuously via an automated indirect calorimetry system (Oxycon Pro). All subjects 
achieved a valid V
 .
O2max as indicated by the plateau criteria (≤200 ml/min increase 
in V
 .





For the exercise trial, subjects reported to the laboratory at 3:00 PM, and 
performed stationary cycling at 70% of V
 .
O2max until a total energy expenditure of 
2.5 MJ (598 kcal) was reached. This exercise protocol was chosen because exercise 
of this intensity and energy expenditure have been shown to consistently reduce PPL 
in response to high fat meals (164). Exercise intensity was verified by measurement 
of V
 .
O2 via indirect calorimetry every 10 min during exercise. The exact work rate 
and duration of exercise for each subject are presented in Supplemental Table 5.I. For 
the control trial, subjects remained sedentary for the 24 hours prior to the PPL test. 
Subjects were instructed to maintain the same dietary habits for 72 hr preceding each 
PPL test, which was verified by dietary logs. 
Because the effect of exercise on PPL is influenced by the timing, caloric content, 
and composition of meals ingested following exercise (80), participants consumed a 
meal of fixed macronutrient composition (40% carbohydrate, 30% fat, and 30% 
protein) between 7:00 and 8:00 PM, as described previously (197). This meal 
consisted of commercially available Zone Perfect bars (Abbott Nutrition, Columbus, 
OH). The number of bars eaten by each participant was calculated and portioned by 
weight to provide 0.5 g of carbohydrate/kg BW and 20.9 kJ/kg BW. Subjects were 
asked to sleep for at least 8 hr prior to PPL testing.  
PPL tests began at 6:00 AM on the morning following each treatment and were 
performed as described by our laboratory previously (247). The test meal contained 
heavy whipping cream, sugar, chocolate syrup, and nonfat powdered milk. The size 
of the test meal was normalized to each subject’s body surface area (386 g/2 m2 body 




meal composition for each subject is presented in Supplementary Table 5.II. All 
subjects consumed their test meals within 5 min and the meals were well-tolerated. 
Thirty-ml blood samples (K2EDTA Vacutainer Tubes, Becton Dickinson) were 
obtained at baseline (0 min) and 240 min for isolation of CD34+, CD31+/CD14-
/CD34-, and CD31+/CD14+/CD34- CACs.  Plasma and serum samples were obtained 
before the meal and at 1, 2, 3, and 4 hr postprandial for assessment of serum 
triglyceride and oxidized LDL (OxLDL) concentrations and plasma endothelial 
microparticle (EMP) concentrations.  
Immunomagnetic Cell Separation 
Peripheral blood mononuclear cells (PBMCs) were isolated from 0- and 4-hr 
samples using density gradient centrifugation (Ficoll, GE Healthcare). The CD34+, 
CD31+/CD14-/CD34-, and CD31+/CD14+/CD34- fractions were purified using 
multiple rounds of immunomagnetic cell separation according to the manufacturer’s 
instructions (EasySep® Immunomagnetic Cell Separation Kits, STEMCELL 
Technologies). In the first step, PBMCs were sorted into CD34+ and CD34- fractions. 
The CD34- fraction was then sorted into CD31+/CD34- and CD31-/CD34-. The CD31-
/CD34- fraction was discarded. In the final sorting step, the CD31+/CD34- fraction 
was further divided into CD14+ and CD14- fractions. Each of these sorting procedures 
was performed as follows: cells were resuspended in PBS + 2% FBS at a density of 2 
× 108 cells/ml. The positive selection antibody cocktail was added (100 µl/ml) to the 
cell suspension and incubated at room temperature for 15 min. Magnetic 
microparticles were then added (100 µl/ml) and incubated for 10 min, and PBS + 2% 




incubated in the selection magnet for 5 min. Positively-selected cells remained 
attached to the side of the tube, and negatively-selected cells were poured off in the 
supernatant. The magnetic incubation step was repeated, and positive and negative 
cell fractions were counted by hemocytometer. The validity of the CD34+ PBMC 
immunomagnetic selection procedure has been previously confirmed in our 
laboratory (108).  For validation of the CD14 and CD31 selection procedures, CD14-, 
CD14+, CD31+, and CD31- selected fractions were analyzed by RT-PCR. RNA was 
isolated and converted to cDNA as described below and cDNA was assessed for 
CD31 and CD14 gene products using PCR and followed by electrophoresis on 
ethidium bromide-stained 1.5% agarose gels (CD31 forward primer: 5’-
CCCAGGAGCACCTCCAGCC-3’; CD31 reverse primer: 
GGACCTCATCCACCGGGGCT-3’;  CD14 forward primer: 5’- 
GGGCGCCTGAGTCATCAGGACAC-3’; CD14 reverse primer: 5’-
CAAGGTTCTGGCGTGGTCGCA-3’). 18S was used as the reference gene. 18S 
primer sequences were published previously (109). For both selection antibodies, 
positively-selected cells displayed strong expression of the target antigens, while 
CD31 and CD14 mRNAs were not detectable in the negatively-selected fractions 
(Supplemental Figure 5.I).  
Pharmacological Treatments and Measurement of Intracellular NO and ROS 
These experiments were performed in duplicate as we have described previously 
(108, 109), with modifications to examine freshly-isolated cells in a 96-well format. 
Briefly, 1.5 × 105 cells stained with 10 µM DAF-FM diacetate for determination of 




(H2DCFDA) for determination of intracellular ROS levels (Molecular Probes). DAPI 
(750 ng/ml) was used to label cell nuclei (Molecular Probes). Cells were also 
incubated with or without 250 µM apocynin (a pharmacologic NADPH oxidase 
inhibitor) and/or 1 µM rotenone (an inhibitor of mitochondrial complex I) to 
determine the contribution of NADPH oxidase- and mitochondrial-derived ROS to 
any observed effects of PPL  and/or exercise on intracellular ROS and NO levels. 
Rotenone treatments were performed on cells from a subset of subjects (n = 5), and, 
owing to limiting cell yields, were only performed on cells that were analyzed for 
intracellular ROS levels. Cells were incubated with fluorescent dyes and drug or 
vehicle treatments in a final volume of 150 µl serum-free PBS for 60 min at 37°C. 
Plates were then centrifuged at 500g for 5 min and cells were resuspended in 150 µl 
PBS. NO and ROS fluorescence were quantified using a fluorescent plate reader 
(Wallac Victor2 1400, Perkin Elmer) using excitation and emission filters of 488 and 
535 nm, respectively. DAPI fluorescence was measured using excitation and emission 
filters of 355 and 460 nm, respectively. NO and ROS fluorescence values were 
divided by DAPI fluorescence values for normalization to cell number, and data are 
expressed relative to the mean for the no exercise 0-min value. Intra-assay 
coefficients of variation for NO and ROS were both 5%. Because each assay was 
performed on different days for each subject, inter-assay coefficients of variation 
were determined on blank samples (PBS only) to document the day-to-day variability 
in arbitrary/background fluorescence. The inter-assay coefficients of variation were 
5% and 4% for NO and ROS assays, respectively, indicating good day-to-day 




PBMCs and the immunomagnetically-selected CAC populations (n = 3 pilot 
experiments) were treated with a NOS inhibitor (L-NAME) and the NO donor, (3-
morpholino-sydnomine). L-NAME reduced DAF fluorescence signals to ~10-20% of 
basal levels, while 3-morpholino-sydnomine dose-dependently increased the DAF 
signal by ~1200-1800 fold compared to basal levels. Similarly, for validation of the 
ROS probe H2DCFDA, the SOD mimetic reduced DCF fluorescence by >50% in all 
cell populations, whereas 3-morpholino-sydnomine (also ROS donor) increased DCF 
fluorescence by ~1000 fold compared to basal levels.  
Intracellular Lipid Assay 
In cells from a subset of subjects (n = 5), intracellular lipids were measured with 1 
µM BODIPY 493/503 (Molecular Probes), a stain for intracellular nonpolar lipids, 
using excitation and emission filters of 488 and 535 nm, respectively. Stored neutral 
lipid fluorescence values were divided by DAPI fluorescence for normalization to cell 
number. Data are expressed as percent change from 0 to 240 min within each 
experimental condition.    
Assessment of Gene Expression by RT-PCR 
RNA was isolated using the TRI reagent and reversed transcribed to cDNA. 
mRNA levels of endothelial/angiogenic [endothelial nitric oxide synthase (eNOS) 
and vascular endothelial growth factor (VEGF)], pro-oxidant [inducible NOS (iNOS), 
oxLDL receptor (LOX-1), and NADPH oxidase subunits gp91phox and p47phox], and 
antioxidant genes (SOD1 and SOD2) were assessed using semiquantitative RT-PCR. 
eNOS, gp91phox, p47phox, SOD1, and SOD2 primer sequences are published 




AAGGAGGAGGGCAGAATCAT-3’, reverse primer: 5’-
ATCTGCATGGTGATGTTGGA-3’), iNOS (forward primer: 5’-
GGCCGCAGAGAACTCAGCCTCA-3’, reverse primer: 5’-
CTCAAAACAGCCGCTTCCCCAGAA-3’), and the oxLDL receptor-1 (LOX-1; 
forward primer: 5’-TTACTCTCCATGGTGGTGCC-3’, reverse primer: 5’-
AGCTTCTTCTGCTTGTTGCC-3’). Gene products were amplified using optimized 
thermal cycling conditions followed by electrophoresis on ethidium bromide-stained 
1.5% agarose gels. For each target gene, all samples within each cell type were run on 
the same gel. Gels were visualized under UV light, and band intensities were 
quantified using ImageJ. Data were normalized to the reference gene 18S, and are 
presented relative to the normalized value for the control 0-hr condition (set at 100%). 
Serum Triglyceride and Oxidized LDL-cholesterol Concentrations 
Serum TG concentrations were examined using a standard colorimetric assay 
(Sigma), as described by our laboratory previously (247). Total areas under the TG 
curves (TG AUC) were calculated using the trapezoidal principle (140). The TG 
intra-assay coefficient of variation was 6.5%, and the inter-assay coefficient of 
variation was 8.5%. Serum levels of oxidized LDL cholesterol (OxLDL) were 
determined using a sandwich ELISA (Mercodia) according to the manufacturer’s 
instructions. Serum OxLDL was measured at 0- and 4-hr only. The OxLDL assay 
intra-assay coefficient of variation was 4%. All samples were analyzed in the same 
batch to eliminate inter-assay variability.   




Preparation of Plasma: Plasma samples were thawed at room temperature and 
centrifuge at 1500g x for 20 minutes at room temperature to obtain platelet poor 
plasma (PPP), The top 2/3 volume of PPP was further centrifuged at 1500g for 20 
minutes at room temperature to obtain cell free plasma (CFP) (194).  The supernatant 
was used for microparticle analysis (58). A volume of 100 μl supernatant was 
incubated with the different fluorochrome-labeled antibodies for 20 minutes at room 
temperature in the dark. Two different antibody combinations were used: CD31-
phycoerythrin (PE, 20 μl/ sample) with CD42b-fluorescein isothiocyanate (FITC, 20 
μl/sample), CD62E-PE (15 μl/sample). All antibodies were obtained from BD 
Biosciences. Samples were diluted with 500 ml of 0.22 μm double -filtered PBS 
before flow cytometric analysis. 
Detection of endothelial microparticles using flow cytometry: Samples were 
analyzed using a BD LSRII flow cytometer and BD FACSDIVA software. EMPs 
were defined as CD31+CD42b- or CD62E+ events smaller than 1.0 μm.  A 
logarithmic scale was implemented for forward scatter signal, side scatter signal and 
each fluorescent channel; size calibration was done with 0.9 μm standard precision 
NIST Traceable polystyrene particle beads (Polysciences, Inc.) and forward scatter 
signal. Fluorescence minus one (FMO) controls and non-stained samples were used to 
discriminate true events from noise, and to increase the specificity for microparticle 
detection for each sample. The flow rate was set on medium on LSRII and all samples 
were run for 180 seconds.  Using beads, we calculated that, on medium flow rate, a 
mean sample volume of 101 μl/ 180 seconds was processed. EMP counts per μl 




(Example for CD31+/CD42- events): 
Number of CD31+/CD42- events      ×     Total volume of sample 
Volume sample analyzed                            Amount of PPP 
Where: the total volume of the sample equals 100 μl PPP stained with 20 μl 
CD42b-FITC and 20 μl of CD31-PE diluted with 500 μl PBS, 93 μl formaldehyde; 
(733 μl for CD31+ CD42- and 713 μl for CD 62E), the volume of the sample 
analyzed by the flow cytometer in 180 seconds equals 101 μl; and the amount of PPP 
used for the analysis is 100 μl (232). 
Supplemental Results – RT-PCR 
In CD31+/CD14-/CD34+ cells, eNOS mRNA levels were higher in the trial with 
exercise compared to control (P < 0.05), but were unaffected by PPL during either 
trial (Supplemental Fig 5.IIA). iNOS mRNA was unaffected by PPL in the control 
trial, but increased significantly with PPL in the trial with prior exercise (P < 0.05) 
such that iNOS levels were higher at the 4 hr PPL time point during the prior exercise 
trial compared to the 4 hr PPL time point of the control trial (P < 0.05; Fig 5.IIB). 
VEGF mRNA levels significantly decreased with PPL during the control trial (P < 
0.05), yet increased significantly during the prior exercise trial (P < 0.05; Fig 5.IIC). 
SOD1 mRNA increased with PPL during the control trial (P < 0.05; Fig 5.IID), but 
there was no effect of PPL in the prior exercise trial (Fig 5.IID). There were no 
effects of PPL or differences between trials for SOD2 or gp91phox mRNA levels (Fig 
5.IIE-F). p47phox and LOX-1 (Fig 5.IIG-H) mRNA levels displayed similar patterns in 




although both of these genes were significantly increased in the trial with prior 
exercise (P < 0.05).  
In CD31+/CD14+/CD34- cells, PPL increased eNOS mRNA in the control trial (P 
< 0.05) but there was no change in the prior exercise trial (Fig 5.IIIA). There were no 
changes in iNOS mRNA with PPL during either trial (Fig 5.IIIB). VEGF mRNA was 
significantly reduced at 0 hr in the prior exercise trial compared to 0 hr in the control 
trial (P < 0.05), and tended to increase (P = 0.07) in the prior exercise trial (Fig 
5.IIIC). There were no effects of PPL during either trial on SOD1 or SOD2 mRNA 
levels (Fig 5.IIID-E). gp91phox mRNA did not change significantly with PPL in the 
control but increased significantly in the trial with prior exercise (P < 0.05; Fig 
5.IIIF). PPL induced significant increases in p47phox mRNA in both trials (P < 0.05; 
Fig 5.IIIG). LOX-1 mRNA levels were higher at both time points of the prior exercise 
trial compared to the control trial (P < 0.05) but were unaffected by PPL in both trials 
(Fig 5.IIIH). 
In CD34+ cells, eNOS mRNA increased significantly with PPL in the control trial 
but there was no change in the prior exercise trial (Supplemental Fig 5.IVA). There 
were no effects of exercise or lipemia on iNOS, VEGF, SOD1, SOD2, or gp91phox 
mRNA (P > 0.05; Fig 5.IVB-F). p47phox increased significantly with PPL during both 
the control and prior exercise trials (P < 0.05; Fig 5.IVG). LOX1 mRNA was 




Supplemental Table 5.I. Duration of submaximal exercise at 70% V
  .







O2max Work rate Duration 
ID (kg) (ml/kg/min) (ml/kg/min) (L/min) (Watts)* (min)** 
01 78.4 50.0 35.0 2.74 203 43.5 
02 63.4 61.1 42.8 2.71 210 44.1 
03 72.6 54.5 38.2 2.77 209 43.2 
04 97.0 50.5 35.4 3.43 255 34.9 
05 64.0 42.1 29.5 1.89 133 63.3 
06 87.5 52.2 36.5 3.20 239 37.4 
07 83.2 47.0 32.9 2.74 199 43.7 
08 87.5 41.6 29.1 2.55 179 46.9 
09 81.1 42.0 29.4 2.38 168 50.1 
10 68.6 38.9 27.2 1.87 129 63.9 
    
Mean 78.3 48.0 33.6 2.6 193 47.1 
SD 11.1 7.0 4.9 0.5 41 9.7 
SEM 3.5 2.2 1.5 0.2 13 3.1 
*Calculated using the American College of Sports Medicine for V
 .
O2 during cycle ergometry (6): V
 .
O2 
= Watts/Mass × 10.8 + 7.  
**Time required to reach an energy expenditure of 2.5 MJ (598 kcal) using assumption that 1 L O2 


































01 172.5 69 1.91 364 12.3 1303 36 182 1121
02 139.5 67 1.71 325 11.0 1164 33 163 1001
03 159.7 69 1.84 350 11.8 1254 35 176 1078
04 213.4 72 2.16 411 13.9 1472 41 206 1266
05 140.9 66 1.70 323 10.9 1157 32 162 995
06 192.5 71 2.05 389 13.1 1394 39 195 1199
07 183.0 73 2.05 389 13.1 1393 39 195 1198
08 192.5 73 2.08 395 13.4 1417 40 198 1218
09 172.5 69 1.91 364 12.3 1303 36 182 1121
10 151.0 70 1.82 346 11.7 1241 35 174 1067
     
Mean 172 70 2 365 12 1310 37 183 1126
SD 24 2 0.2 30.1 1.0 108 3 15 93
SEM 8 1 0.05 9.5 0.3 34 1 5 29





Supplemental Figure 5.I. Validation of immunomagnetic separation of CD31+ (left) and 








Supplemental Figure 5.II. Effects of postprandial lipemia with and without prior endurance 
exercise on eNOS (A), iNOS (B), VEGF (C), SOD1 (D), SOD2 (E), gp91phox (F), p47phox (G), 
and LOX1 (H) mRNA levels in CD31+/CD14-/CD34- cells. *Statistically significant change 
from within-trial 0 hr sample (P < 0.05). †Statistically significant difference from 






Supplemental Figure 5.III. Effects of postprandial lipemia (PPL) with and without prior 
endurance exercise on eNOS (A), iNOS (B), VEGF (C), SOD1 (D), SOD2 (E), gp91phox (F), 
p47phox (G), and LOX1 (H) mRNA levels in CD31+/CD14+/CD34- cells. *Statistically 
significant change from within-trial 0 hr sample (P < 0.05). †Statistically significant 





Supplemental Figure 5.IV. Effects of postprandial lipemia with and without prior endurance 
exercise on eNOS (A), iNOS (B), VEGF (C), SOD1 (D), SOD2 (E), gp91phox (F), p47phox (G), 
and LOX1 (H) mRNA levels in CD34+ cells. *Statistically significant change from within-
trial 0 hr sample (P < 0.05). †Statistically significant difference from corresponding time 




Chapter 6:  Summary and Conclusions 
Summary 
The three studies performed for this dissertation have contributed the following 
new information: (i) regular endurance exercise is associated with greater intracellular 
NO in cultured CACs, partly due to physical activity-dependent down-regulation of 
NADPH oxidase activity (study #1), (ii) a sedentary lifestyle is associated with nitro-
oxidative stress in freshly isolated CD34+ progenitor cells (study #2), and (iii) prior 
endurance exercise prevents PPL-induced increases in ROS production in CD31+ 
CACs (study #3). With a few notable exceptions (discussed in the Discussion section 
of each manuscript), it can be concluded that, in general, the hypotheses outlined in 
Chapter 1 were supported by these findings. Although these studies provide some of 
the first information about the effects of acute and chronic endurance exercise on 
molecular regulators of CAC function, a number of important questions remain for 
future research. 
Perspectives for Future Research 
Is NO a valid surrogate marker for CAC functional capacity? Substantial 
evidence from the literature indicates that exercise training can improve CAC 
function as indicated by migratory capacity and reendothelialization assays (93, 198, 
228, 230). It is also generally thought that these functions of CAC functions are 
dependent on the availability and actions of NO (61, 250). However, the present data 
(from study #2) indicating an inverse relationship between exercise training status 
and intracellular NO levels in CD34+ cells would suggest that NO may not be an all-




amount of information relative to the beneficial health consequences of exercise, it is 
unlikely that the lower NO levels in CD34+ cells from the trained group should be 
taken as an indicator that these cells were dysfunctional. Rather, the discrepancy 
probably reflects the dual role that NO plays in cells of the immune system. NO is 
elevated in nitro-oxidative stress and, in high concentrations, can play a role in 
inflammatory responses (159, 213). As discussed in Chapter 4, it is likely that the 
higher NO levels (combined with higher O2     ·-
 
, higher iNOS mRNA levels, and lower 
eNOS mRNA levels) in CD34+ cells from the sedentary group is suggests a pro-
inflammatory/pro-oxidative cell phenotype associated with a sedentary lifestyle. 
Although this conclusion was somewhat speculative, there is substantial evidence that 
sedentary behavior increases systemic inflammation and oxidative stress (163). 
Unfortunately, it was not possible to prove that the higher NO in cells from sedentary 
individuals in study #2 was linked to chronic inflammation/oxidative stress given the 
cross-sectional study design. Also, it would have been advantageous to have had a 
measure of angiogenic capacity (e.g., in vitro vessel formation, which was not 
performed because of limiting cell yields), as such data would have been helpful in 
interpreting whether higher NO levels were associated with impaired CAC function. 
Nevertheless, it is reasonable to suggest that the role of NO as a marker of CAC 
functional capacity needs to be re-evaluated. Future exercise studies must link 
measures of NO and ROS to measures of CAC function to definitively clarify the 
mechanistic role of NO-ROS dynamics in exercise-induced alterations in CAC-




Are CACs required for exercise training-induced effects on the vasculature? The 
present studies focused on genes (antioxidant defenses, pro-oxidant enzymes, and 
regulators of angiogenesis) and intracellular molecules (NO and ROS) that had 
previously been implicated in functional activities of CACs. However, these 
experiments may have been somewhat premature, because at this point we still do not 
know whether or to what extent CACs are actually involved in exercise training 
effects on the vascular endothelium. Probably because of technical limitations, no 
studies have examined the effect of in vivo CAC depletion on exercise training-
induced angiogenesis or effects on endothelial function. However, pharmacologic 
manipulation of circulating monocyte concentrations in rodents indicated that VEGF- 
and ischemia-induced angiogenesis is impaired in the presence of low circulating 
monocyte levels (86). Clearly a similar approach applied to an exercise training 
model would provide critical information to form appropriate hypotheses dealing with 
the effects of acute exercise or exercise training on CAC number and function. Thus, 
although we know that regular exercise can prevent or delay the onset of endothelial 
dysfunction and CV disease, or even reverse existing CV pathologies, future work 
must determine whether and quantify the extent to which CACs are involved in 
mediating the effects exercise training on CV health.  
Cell therapy: the future of exercise-based CAC research? While the present 
research investigations were underway, a substantial number of papers were 
published on the use of CACs as a source for cell therapeutic treatment of ischemic 
CV diseases. A recent review of 19 published cell therapy studies and 31 registered 




medicine” using cell therapy is promising, the results are too variable for widespread 
clinical use (156). Current strategies to improve the efficacy of cell therapy include 
the use of mobilizing agents, pharmacologic adjuvants, ex vivo CAC expansion, and 
gene modification (156). One strategy conspicuously absent from this list is exercise, 
and, indeed, our laboratory has recently proposed that exercise may be one way to 
improve CAC-mediated regenerative angiogenesis (250). Specifically relating to the 
results of the present studies, the following hypotheses are proposed. Based on study 
#1, preconditioning patients with a bout of acute exercise prior to ex vivo expansion 
in culture may reduce oxidative stress and increase NO bioavailability of CACs to be 
used for therapy. From study #2, it might be expected that an exercise training 
intervention prior to CAC infusions would reduce nitro-oxidative stress and increase 
the expression of genes involved in angiogenesis in CD34+ progenitor cells, a cell 
population that was recently shown to improve left ventricular function after coronary 
artery infusion in post-myocardial infarction patients (171). Finally, the results of 
study #3 would suggest that exercise might improve the ability of CD31+ cells, 
recently shown to be effective source of cell therapy in rodent models of ischemic CV 
disease (114, 115), to better cope with an inflammatory/pro-oxidative challenge and 
thereby result in improved therapeutic outcomes.    
Conclusions 
Overall, it is concluded that acute and chronic endurance exercise enhance 
intracellular NO and ROS dynamics in CACs. The nature and direction of these 
effects appear to vary according to methodological approaches, such as cultured vs. 




subpopulations. The roles of NO and ROS in CAC function and the extent to which 
CACs contribute to exercise training-induced improvements in vascular endothelial 
function will require clarification in future studies. Finally, the present studies may 
provide useful information for the development of future examinations of whether 
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 This is a research project being conducted by Dr. James Hagberg in the Department of 
Kinesiology at the University of Maryland College Park. We are inviting you to participate in 
this research project because you are 18 – 35 years of age, are generally healthy, and have a long 
history of exercise/physical activity. The purpose of this study is to determine whether aging and 
regular exercise are associated with novel risk factors related to cardiovascular disease. In this 
case, “novel” risk factors mean newer risk factors beyond the standard risk factors such as 
cholesterol levels, blood pressure, diabetes, and obesity. In a subset of exercisers we will 
determine the degree to which these risk factors change when they stop exercising for 10 days. 
Two groups of older participants, one consisting of life-long exercisers and the other of generally 
sedentary individuals, have already completed the study. We recruit you for the study because 
we would like to compare the levels of novel risk factors from these older groups to those from 
younger individuals who exercise regularly. Your participation in this research is completely 
voluntary and you may choose not to take part at all. You are free to ask questions at any time 
without penalty. If you decide to participate in this research, you may stop participating at any 
time. If you decide not to participate in this project or if you stop participating at any time, you 
will not be penalized or lose any benefits to which you otherwise qualify. The specific tests, their 
requirements, and time commitments are described below.  
 
 Participant Characteristics: You have already completed a telephone or personal 
interview that you verbally consented to that determined that you are 18 – 35 years of age, 
regularly engage in endurance exercise such as running or cycling, are not a diabetic, have no 
evidence of cardiovascular or lung disease, and have no other medical problems that keep you 
from exercising vigorously. We have also discussed with you that certain medications may 
exclude you from taking part in this study. 
 
Study Procedures: If you qualify and complete the phase of this study where you stop 
exercising for 10 days, your total involvement in this study will consist of 3 visits over 2 – 3 
wks. If you do not undergo the 10 days of stopping exercise, your total involvement will consist 
of 2 visits over approximately 1 week.   
  
 Screening Visit: For the Screening Visit, the study will be explained to you, your 
medical history will be reviewed, and you will be asked to provide your written informed 
consent. Your resting blood pressure will be measured and about 2 tablespoons of blood will be 
drawn from a vein in your arm. Your body composition will be assessed by a procedure that 
involves measuring the thickness of your skinfolds. You will then undergo a treadmill exercise 
test to determine your maximal exercise capacity. This test will be done on an exercise treadmill 
where the treadmill incline will increase every 2 minutes until you cannot continue. Blood 
pressure, heart rate, and the electrical activity of your heart (electrocardiogram) will be recorded 
before, during, and after the test. During this test you will have a noseclip on your nose and you 
will breathe through a mouthpiece so that the air that you breathe out can be analyzed. This visit 
will last about 1 hour. 
 
134
Project Title: Life-Long Exercise and Novel Cardiovascular Disease and Aging 
Risk Factors – Young Active Participants 
 
Page 2 of 4             Date ______________ Initials ____________ 
 
 Testing Visit #1: For the first Testing Visit, you will report to the laboratory in the 
morning after an overnight fast (only taking in water from 8 PM the night before). Prior to this 
visit you will record all items that you eat over a 7 day period. About 4 tablespoons of blood will 
be drawn from a vein in your arm. You will then undergo treadmill exercise for 30 minutes at a 
moderate to vigorous intensity. Heart rate and blood pressure will be monitored before, during, 
and after the exercise. During this test you will have a noseclip on your nose and you will 
breathe through a mouthpiece so that the air that you breathe out can be analyzed. At 5 and 30 
minutes after the exercise approximately 4 tablespoons of blood will be drawn from a vein in 
your arm. The blood samples that you provide before and after exercise will be tested for levels 
of the new cardiovascular disease risk factors. This visit will last about 1.5 hours.  
 
 If you are not undergoing the 10 days without exercise, this is all the testing that is 
required of you. If you are undergoing the 10 days without exercise phase of the study, you will 
undergo 1 additional visit to the laboratory.   
 
 Testing Visit #2: Following 10 days of training cessation, you will report to the 
laboratory for a blood draw and a second assessment of your body composition. During the 
period of training cessation, we ask that you monitor your weight to ensure that you do not gain 
or lose any weight when you are not exercising. If you change any of your medications during 
this phase of the study, please notify one of the researchers.  This visit will last about 30 minutes. 
 
 The maximum total amount of blood that will be drawn during the testing is about 12 
tablespoons if you are not undergoing the 10 days without exercise and about 18 tablespoons 
over the space of 2 – 3 weeks if you are undergoing the 10 days without exercise. This is 
approximately 1/3 and 1/2, respectively, of the amount of blood that is typically drawn during a 
single blood donation. These samples will be used to measure a number of chemicals and cell 




o take part in Testing Visit #2 
 
⁮ Yes, I consent to having my blood drawn and saved for future analyses 
⁮ No, I do not consent to having my blood drawn and saved for future analyses and my samples 
must be destroyed after the completion of this study.  
 
 Confidentiality: We will do our best to keep your personal information confidential. To 
help protect your confidentiality, all data are kept in a locked office with access available only to 
study personnel. Furthermore, all computer data bases containing results from this study will not 
have any names attached to them. If we write a report or article about this research project, your 
identity will be protected to the maximum extent possible. Your information may be shared with 
representatives of the University of Maryland College Park or government authorities if you or 
someone else is in danger or if we are required to do so by law.  
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 Samples of your blood will be sent to other collaborating laboratories for other blood 
measurements. Your blood samples sent to these laboratories will be identified only by a 
numeric code and only investigators at the University of Maryland College Park will know 
whose name is associated with each coded number. The list of names and codes will be retained 
at the University of Maryland College Park for up to 25 years.  
 
 Risks: The following risks are associated with your participation in this study. (1) There 
is some risk associated with maximal exercise testing but complications are unusual in healthy 
individuals in your age group (Gibbons et al., 1989, Circulation Vol. 80, No. 4).  Risks will be 
minimized by having the test administered by personnel trained in such tests and emergency 
procedures. You will gradually cool down upon reaching your highest effort, which will further 
help to reduce the risk of complications. A cardiac defibrillator will be present at all testing 
sessions. (2) There are risks of bruising and infection associated with blood drawing. These risks 
will be minimized by using sterile techniques and by having experienced personnel draw all 
blood samples. (3) The skinfold body composition testing has no known risks. (4) The risk of 
stopping your exercise for 10 days, if you complete this portion of the study, is that your risk 
factors for cardiovascular disease may deteriorate. It is unlikely that substantial changes will take 
place over the space of the 10 days without exercise. Furthermore, you will be able to start 
exercising again immediately after these 10 days without exercise. (5) There are no known risks 
associated with completing 7 day dietary records. (6) Your involvement will require some 
amount of time, travel, and effort. Your parking costs will be covered. 
 
 Benefits: This study may not help you personally, but may help the investigators to 
determine whether regular exercise results in better levels of new cardiovascular disease risk 
factors. Because you are a young and healthy participant, and you are therefore not at elevated 
risk for cardiovascular disease because of increasing age, your participation will help us to learn 
about these new risk factors in a group of people who are at very low risk for developing 
cardiovascular disease. You will also help us to learn what happens to the new risk factors after 
10 days of no physical activity. You might benefit because you will receive information about 
your current cardiovascular fitness and body fat levels, and you will be told of any abnormalities 
found during testing and will be advised to consult your personal physician. You will also be told 
of your results of the different risk factors that we measure and will be provided an explanation 
of these results.  
 
 Emergency Information: In the event of a physical injury resulting from participation in 
this study, medical attention is available at the Washington Adventist Hospital. The University of 
Maryland does not provide any medical, hospitalization, or other insurance for participants in 
this research study nor will the University of Maryland provide any medical treatment or 
compensation for any injury sustained as a result of participation in this research study except as 
required by law. 
 
 Contact Information: This research is being conducted by James Hagberg PhD of the 
Department of Kinesiology at the University of Maryland. If you have any questions about the 
research study itself, please contact Dr. Hagberg at 301-405-2487 (office) or via email at 
hagberg@umd.edu. If you have questions about your rights as a research subject or wish to 
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report a research-related injury, please contact: Institutional Review Board Office, University 
of Maryland, College Park, MD 20742; email: irb@deans.umd.edu; telephone: 301-405-
0678. 
 
 This research has been reviewed according to the University of Maryland College Park 
IRB procedures for research involving human subjects.  
 
 Your signature below indicates that you are at least 18 years of age, the research has 
been explained to you, your questions have been fully answered, and you freely and 




Participant’s printed name 
 
 
_________________________________   ______________________ 
Participant’s signature     Date 
 
 
_________________________________   ______________________ 
Witness Signature      Date 
 
 
_________________________________   ______________________ 
Investigator Signature      Date 
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 This is a research project being conducted by Dr. James Hagberg in the Department of 
Kinesiology at the University of Maryland College Park. We are inviting you to participate in 
this research project because you are 18 – 35 years of age, are generally healthy, and are 
generally sedentary. The purpose of this study is to determine whether aging and regular exercise 
are associated with novel risk factors related to cardiovascular disease. In this case “novel” risk 
factors mean newer risk factors beyond the standard risk factors of cholesterol levels, blood 
pressure, diabetes, and obesity. Two groups of older participants, one consisting of life-long 
exercisers and the other of generally sedentary individuals, have already completed the study. 
We recruit you for the study because we would like to compare the levels of novel risk factors 
from these older groups to those from younger individuals who do not exercise regularly. Your 
participation in this research is completely voluntary and you may choose not to take part at all. 
You are free to ask questions at any time without penalty. If you decide to participate in this 
research, you may stop participating at any time. If you decide not to participate in this project or 
if you stop participating at any time, you will not be penalized or lose any benefits to which you 
otherwise qualify. The specific tests, their requirements, and time commitments are described 
below.  
 
 Participant Characteristics: You have already completed a telephone or personal 
interview that you verbally consented to that determined that you are 18 – 35 years of age, are 
not a diabetic, have no evidence of cardiovascular or lung disease, and have no other medical 
problems that keep you from exercising vigorously. We have also discussed with you that certain 
medications may exclude you from taking part in this study. 
 
Study Procedures: If you qualify and complete this study, your total involvement will 
consist of 2 visits over approximately 1 week, including 1 Screening Visit and 1 Testing Visit.  
 
 Screening Visit: For the Screening Visit, the study will be explained to you, your 
medical history will be reviewed, and you will be asked to provide your written informed 
consent. Your resting blood pressure will be measured and about 2 tablespoons of blood will be 
drawn from a vein in your arm. Your body composition will be assessed by a procedure that 
involves measuring the thickness of your skinfolds. You will then undergo a treadmill exercise 
test to determine your exercise capacity. This test will be done on an exercise treadmill where the 
treadmill incline will increase every 2 minutes until you cannot continue. Blood pressure, heart 
rate, and the electrical activity of your heart (electrocardiogram) will be recorded before, during, 
and after the test. During this test you will have a noseclip on your nose and you will breathe 
through a mouthpiece so that the air that you breathe out can be analyzed. This visit will last 
about 1 hour. 
 
 Testing Visit: For the Testing Visit, you will report to the laboratory in the morning after 
an overnight fast (only taking in water from 8 PM the night before). Prior to this visit you will 
record all items that you eat over a 7 day period. About 4 tablespoons of blood will be drawn 
from a vein in your arm. You will then undergo treadmill exercise for 30 minutes at a moderate 
to vigorous intensity. Heart rate and blood pressure will be monitored before, during, and after 
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the exercise.  During this test you will have a noseclip on your nose and you will breathe through 
a mouthpiece so that the air that you breathe out can be analyzed. At 5 and 30 minutes after the 
exercise approximately 4 tablespoons of blood will be drawn from a vein in your arm. The blood 
samples that you provide before and after exercise will be tested for levels of the new 
cardiovascular disease risk factors. This visit will last about 1.5 hours.  
 
 The maximum total amount of blood that will be drawn during this Testing is about 12 
tablespoons. This is approximately 1/3 of the amount of blood that is typically drawn during a 
single blood donation. These samples will be used to measure a number of chemicals and cell 
numbers in the blood that may be related to a person’s risk of cardiovascular disease.  
 
⁮ Yes, I consent to having my blood drawn and saved for future analyses 
⁮ No, I do not consent to having my blood drawn and saved for future analyses and my samples 
must be destroyed after the completion of this study.  
 
 Confidentiality: We will do our best to keep your personal information confidential. To 
help protect your confidentiality, all data are kept in a locked office with access available only to 
study personnel. Furthermore, all computer data bases containing results from this study will not 
have any names attached to them. If we write a report or article about this research project, your 
identity will be protected to the maximum extent possible. Your information may be shared with 
representatives of the University of Maryland College Park or government authorities if you or 
someone else is in danger or if we are required to do so by law.  
 
 Samples of your blood will be sent to other collaborating laboratories for other blood 
measurements. Your blood samples sent to these laboratories will be identified only by a 
numeric code and only investigators at the University of Maryland College Park will know 
whose name is associated with each coded number. The list of names and codes will be retained 
at the University of Maryland College Park for up to 25 years.  
 
 Risks: The following risks are associated with your participation in this study. (1) There 
is some risk associated with maximal exercise testing but complications are unusual in healthy 
individuals in your age group (Gibbons et al., 1989, Circulation Vol. 80, No. 4).  Risks will be 
minimized by having the test administered by personnel trained in such tests and emergency 
procedures. You will gradually cool down upon reaching your highest effort, which will further 
help to reduce the risk of complications. A cardiac defibrillator will be present at all testing 
sessions. (2) There are risks of bruising and infection associated with blood drawing. These risks 
will be minimized by using sterile techniques and by having experienced personnel draw all 
blood samples. (3) The skinfold body composition testing has no known risks. (4) There are no 
known risks associated completing 7 day dietary records. (5) Your involvement will require 
some amount of time, travel, and effort. Your parking costs will be covered.   
 
 Benefits: This study may not help you personally, but may help the investigators to 
determine whether regular exercise results in better levels of new cardiovascular disease risk 
factors. Because you are a young and healthy participant, and you are therefore not at elevated 
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risk for cardiovascular disease because of increasing age, your participation will help us to learn 
about these new risk factors in a group of people who are at very low risk for developing 
cardiovascular disease. You might benefit because you will receive information about your 
current cardiovascular fitness and body fat levels, and you will be told of any abnormalities 
found during testing and will be advised to consult your personal physician. You will also be told 
of your results of the different risk factors that we measure and will be provided an explanation 
of these results.  
 
 Emergency Information: In the event of a physical injury resulting from participation in 
this study, medical attention is available at the Washington Adventist Hospital. The University of 
Maryland does not provide any medical, hospitalization, or other insurance for participants in 
this research study nor will the University of Maryland provide any medical treatment or 
compensation for any injury sustained as a result of participation in this research study except as 
required by law. 
 
 Contact Information: This research is being conducted by James Hagberg PhD of the 
Department of Kinesiology at the University of Maryland. If you have any questions about the 
research study itself, please contact Dr. Hagberg at 301-405-2487 (office) or via email at 
hagberg@umd.edu. If you have questions about your rights as a research participant or wish to 
report a research-related injury, please contact: Institutional Review Board Office, University 
of Maryland, College Park, MD 20742; email: irb@deans.umd.edu; telephone: 301-405-
0678. 
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This research has been reviewed according to the University of Maryland College Park 
IRB procedures for research involving human participants.  
 
Your signature below indicates that you are at least 18 years of age, the research has 
been explained to you, your questions have been fully answered, and you freely and 
voluntarily choose to participate in this research program.  
 
_________________________________ 
Participant’s printed name 
 
_________________________________   ______________________ 
Participant’s signature     Date 
 
_________________________________   ______________________ 
Witness Signature      Date 
 
_________________________________   ______________________ 
Investigator Signature      Date 
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This is a research project being conducted by James M. Hagberg,
Ph.D. at the University of Maryland, College Park. We are
inviting you to participate in this research project because you are
a healthy, physically active male between the ages of 18 and 35
with no history of cardiovascular or metabolic disease. You have
already indicated by phone or email interview that you meet these
criteria and also that you have no history of lactose intolerance
(an inability to digest dairy products) or other disorders of the
digestive system. The purpose of this research project is to
investigate the effects of a high-fat meal on recently-discovered
proteins and cell types in the blood. We are also interested in
whether exercise performed on the day before eating a high fat
meal alters these effects. Because most of us in modern Western
societies are almost always in a “postprandial” state (i.e., we have
usually had a recent large meal), the results of this study will have
important implications for a large number of people. The
experimental protocol (described in detail below) involves
performing exercise or no exercise on the day before a
“postprandial lipemia” test. Postprandial lipemia simply means
measuring the levels of fat (triglycerides) appearing in your blood
after eating a high-fat meal (a chocolate milkshake).
What will I be
asked to do?
This study involves 5 visits to the laboratory, totaling 15.5 hours
of your time:
Visit #1: ASSESSMENT OF BODY COMPOSITION,
CARDIOVASCULAR RISK FACTORS, AND AEROBIC
CAPACITY. On the 1st visit, you will read and sign the informed
consent, and complete and submit the physical activity history
and medical history forms. Your height will then be measured on
a metric scale and body composition will be assessed using the
skinfold method, in which skinfold thickness is measured using
calipers at 7 sites on your body. Blood pressure will be measured,
and a fasting blood sample will be obtained (1 tsp). The purpose
of this blood draw is to exclude any subjects from further testing
who have blood cholesterol levels: LDL or “bad” cholesterol
above 130 mg/dl; HDL or “good” cholesterol below 40; or total
cholesterol above 200 mg/dl). Subjects with high blood glucose
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values (i.e., above 100 mg/dl) will also be excluded from further
testing. Following the body composition assessment and blood
draw, your maximal oxygen uptake (a measure of the fitness of
your cardiovascular system) will be tested on a stationary bicycle.
This test will begin at a low intensity, and the intensity will
increase every two minutes until you can no longer continue. The
test is designed to last ~6-12 minutes. Your expired air will be
collected using a specialized mouthpiece and analyzed. This visit
will last a total of 1 to 1.5 hours.
Visit #2: CONTROL TRIAL OR EXERCISE TRIAL. For the 2nd
and 4th visits, you will report to the laboratory at 4:00 PM having
not ingested any food 3 hours before the treatment protocol. The
order of the control and exercise treatments will be randomized.
This visit will last approximately 1.5 hours.
EXERCISE TRIAL: You will be allowed to ingest only water
during the exercise treatment and the ingested volume will be
recorded. The exercise protocol will consist of cycling at an
intensity corresponding to 70% of your maximal exercise
capacity measured during visit #1. You will exercise until you
have burned 600 Calories. We anticipate that you will perform
about 45 minutes of exercise (between 30 and 60 minutes) to
burn 600 Calories at this exercise intensity. Furthermore, after
your maximal exercise test (visit #1), we will be able to
calculate an estimate of the number of minutes it will take you
to burn 600 calories. However, the equation we use is accurate
for most individuals, but it is not perfect for everyone.
Therefore, we will not know exactly how long you will need
to exercise on this visit until you actually perform the
experiment. The estimate we give you has a margin of error of
approximately 5 minutes for most people.
CONTROL TRIAL: You will perform the no-exercise control
trial by reporting to the laboratory at 5 PM and sitting quietly
for the same length of time as is estimated for the exercise
trial.
Following both the exercise and control trials, you will be given
the evening postexercise meal to take home and eat between 7:00
p.m. and 7:30 p.m. This meal will contain two Zone Perfect®
Nutrition Bars. The meal will provide 420 kcals and will contain
no more than 40% carbohydrate (42 g), 30 % fat (14 g), and 30 %
protein (32 g). You will be asked not to eat anything more after
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the evening postexercise meal until your next visit at ~7:00 a.m.
on the following day, and to drink only water during this time.
You may drink as much water you like and to record the volume
on the dietary log.
Visit #3: POSTPRANDIAL LIPEMIA TEST #1. You will report
to the laboratory between 7:00 and 7:15 A.M. in a fasted state as
soon as possible after waking up, having performed no physical
activity during that morning. You will have an intravenous (i.e.,
“IV”) catheter inserted into an easily accessible vein on your arm
by ~7:30 a.m.
You will consume the test meal from ~7:30 A.M. until ~08:00
A.M. The amount you will consume will be determined on the
basis of your body size. An average serving of this test meal
provides 1362 calories (84% fat). The ingredients are heavy
whipping cream, chocolate syrup, sugar, and milk powder. It is
very much like a rich, chocolate milk shake. Immediately upon
completion of the meal, a blood sample will be obtained for the 0-
hr time point. The next blood samples will be obtained at 60
minute intervals after meal ingestion for 4 hours. The venous
catheter will be flushed a standard saline solution after each
sample is obtained to prevent blood from clotting in the line. You
will be allowed to drink water throughout the test and the volume
you drink will be recorded.
The following volumes of blood will be obtained at each
sampling point. The purpose of each sample is including in
parentheses.
Baseline (pre-meal): 4 tsp for examination of fasting triglycerides
and angiogenic growth factor levels
0 hr (immediately upon completion of meal): 8 tsp for isolation of
stem cells measuring angiogenic growth factors
1, 2, and 3 hrs: 4 tsp for measuring angiogenic growth factors and
triglyceride concentrations
4 hr: 8 tsp for isolation of stem cells and measuring angiogenic
growth factors
Therefore, a total of 32 tsp of blood will be obtained during this
test. For comparison, a pint (96 tsp) is given at a blood donation.
This test will last approximately 5.5 hours.
Visit #4: EXERCISE OR CONTROL TRIAL (as described for
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Visit #2). The remaining experimental trial will be completed on
this visit. This visit will occur at least 3 and not more than 10
days after the preceding postprandial lipemia test. This visit will
last approximately 1.5 hours.
Visit #5: POSTPRANDIAL LIPEMIA TEST #2 (exactly as




We will do our best to keep your personal information
confidential. To help protect your confidentiality, you will be
identified by a 2-digit ID number on data forms, questionnaires,
and computer files. Your name will not be included on any of
these forms. Confidentiality will be maintained by developing a
code form that associates the ID numbers with the names of the
participants. The code form will be maintained in a locked, secure
filing cabinet in the Metabolic Testing Laboratory, and only study
personnel will have access to this file. All study
forms/questionnaires will include subjects’ ID numbers only (no
names). If we write a report or article about this research project,
your identity will be protected to the maximum extent possible.
Your information may be shared with representatives of the
University of Maryland, College Park or governmental authorities
if they or others are in danger or if we are required to do so by
law. Data will be kept for a minimum of 3 years and a maximum
of 10 years. Information collected from excluded participants or
participants who withdraw from the study will not be used and
will be destroyed or shredded immediately. Responses from
participants recruited by email will be kept confidential by
printing paper copies of emails and storing them in locked,
secured files according to subject codes. All personally
identifying information (e.g., name and email address) will be
redacted from the printed versions and, all email correspondence
containing any identifying information will be permanently
deleted after securing the hard printed copies.
What are the risks
of this research?
Participation in this study does not involve any known
psychological, social, legal, or economic discomfort or risks.
Physical discomfort may be experienced during exercise along
with minor local discomfort due to the insertion of a venous
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catheter.
The primary risks in this study are (1) physical and mental fatigue
due to the performance of maximal and submaximal exercise, and
(2) physical discomfort from blood drawing, The risks of exercise
will be minimized by: (1) recruiting subjects such as yourself who
are accustomed to vigorous exercise and who have no history of
cardiovascular or metabolic disease, (2) informing you about the
symptoms and signs of strenuous exercise complications and
instructing you to stop exercising if these symptoms or signs
develop, (3) monitoring behavior continuously and terminating
exercise immediately if there are signs of developing illness such
as headache, nausea, mental disorientation, lack of coordination,
or dizziness. Should you develop any signs or symptoms, an
emergency protocol will be immediately initiated and emergency
medical technicians will be called. The probability of avoiding
serious injury is high if emergency care is initiated immediately.
Emergency protocols for handling a cardiovascular problem are
posted in the laboratory at all times and the study personnel are
trained and certified to perform emergency CPR/AED procedures.
All exercise testing procedures and safety protocols in our
laboratory follow the American College of Sports Medicine’s
guidelines for exercise testing. The risks of drawing blood from
the arm include the possibilities of feeling lightheaded or fainting,
development of a small bruise, or infection. These risks will be
minimized by using only qualified and experienced personnel to
draw blood who will follow standard sterile techniques, who will
observe the subject after the catheter is withdrawn, and who will
apply pressure to the blood-draw site.
Additionally, there may be some risk associated with consuming a
high fat meal, including indigestion and/or nausea. However, it is
anticipated that this risk will not be substantially greater than that
faced in day-to-day life, as the test meal is very much like a rich,
chocolate milkshake that might be purchased from a common fast
food chain. The risk of gastrointestinal distress is minimized by
ensuring that you have no history of lactose intolerance or
gastrointestinal disorders.
All testing will be carefully supervised by the investigators and
other trained personnel to reduce the possible risks. In the
unlikely event of an emergency, laboratory personnel trained in
CPR will be present during all test sessions. An AED is present
in the laboratory at all times and is verified to be in proper
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This study may not help you personally. However, you might
benefit by having their body composition assessed and will be
provided information about your height, weight, body fat levels,
aerobic fitness, your current levels of cardiovasuclar disease risk
factors. Finally, you will be helping us understand the effects of
exercise and postprandial lipemia on a recently-discovered
population of cells that repair the cardiovascular system.
Therefore, you will be contributing to the advancement of
important biomedical research by volunteering your time.





Your participation in this research is completely voluntary. You
may choose not to take part at all. If you decide to participate in
this research, you may stop participating at any time. If you decide
not to participate in this study or if you stop participating at any




if I am injured?
The University of Maryland does not provide any medical,
hospitalization or other insurance for participants in this research
study, nor will the University of Maryland provide any medical
treatment or compensation for any injury sustained as a result of
participation in this research study, except as required by law.
What if I have
questions?
This research is being conducted by Dr. James M. Hagberg at
the University of Maryland, College Park. If you have any
questions about the research study itself, please contact Dr.
Hagberg at (301) 405-2487 or by email at hagberg@umd.edu.
If you have questions about your rights as a research subject or
wish to report a research-related injury, please contact:
Institutional Review Board Office, University of Maryland,
College Park, Maryland, 20742; (e-mail) irb@umd.edu;
(telephone) 301-405-0678
This research has been reviewed according to the University of
Maryland, College Park IRB procedures for research involving
human subjects.
Statement of Age of
Subject and
Consent
Your signature indicates that:
you are at least 18 years of age;,
the research has been explained to you;
your questions have been fully answered; and
you freely and voluntarily choose to participate in this research
project.
Subject Signature NAME OF SUBJECT
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